rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATTTCGGGCGGGAGAGCACAGATACGCAGTATTTTGGCCCA	CASSVDFGRESTDTQYF	In	VDJ	1	43	5.300462249614792E-4	6.95905486324648E-4	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	7	2	0	7	0	23	39	-1	46	53			01,02										Vb 1	CASSVDFGRESTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*02	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGGACCTCGGGGGTGAGCAGTTCTTCGGGCCA	CASSVDLGGEQFF	In	VDJ	1	44	5.423728813559322E-4	7.120893348438259E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	2	9	6	0	23	37	-1	43	49			01,02										Vb 1	CASSVDLGGEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGTCAGGCAGGGGGTAGGGGGACGCAGTATTTTGGCCCA	CASSGQAGGRGTQYF	In	VDJ	1	47	5.793528505392912E-4	7.606408804013595E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	1	9	6	7	23	36	49	42	56			01,02										Vb 1	CASSGQAGGRGTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTCGGGGCCACCAGGGGTGAAAAACTGTTTTTTGGCAGT	CASSFGATRGEKLFF	In	VDJ	1	62	7.642526964560863E-4	0.0010033986081890273	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	2	7	11	0	23	35	-1	46	52			01,02										Vb 1	CASSFGATRGEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCCCTAGCGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSVALAAYNEQFF	In	VDJ	1	65	8.012326656394453E-4	0.001051950153746561	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	5	2	2	0	23	39	-1	41	48			01,02			01,02							Vb 1	CASSVALAAYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCTAGCAGCGTATTTGGGGTCGGGGAGACCCAGTACTTCGGGCCA	CASSVFGVGETQYF	In	VDJ	1	79	9.738058551617874E-4	0.001278524033015051	42	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-05	01	1	6	2	5	3	5	23	38	45	41	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVFGVGETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01		TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCTGAGACAGGGTTCGAGCAGTACTTCGGGCCG	CASSVAETGFEQYF	In	VDJ	1	80	9.861325115562403E-4	0.0012947078815342288	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	3	6	4	2	23	39	50	43	52			01,02										Vb 1	CASSVAETGFEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGAGACGGAGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSGDGGTGELFF	In	VDJ	1	125	0.0015408320493066256	0.0020229810648972326	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	10	0	5	5	0	23	36	-1	41	47			01,02										Vb 1	CASSGDGGTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01*02	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACCAAGGGACAGAGGGAGGACAATGAGCAGTTCTTCGGGCCA	CASTKGQREDNEQFF	In	VDJ	1	132	0.0016271186440677966	0.0021362680045314774	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	5	5	4	7	23	33	44	37	51			01,02										Vb 1	CASTKGQREDNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGACTAAAGTCGCCGGGGAGCTGTTTTTTGGAGAA	CASSVGTKVAGELFF	In	VDJ	1	143	0.0017627118644067796	0.002314290338242434	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	1	9	6	0	6	23	-1	45	39	51			01,02			01,02							Vb 1	CASSVGTKVAGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGACAGGTCCGGGACAGGGTTTCCCGGGGAGCTGTTTTTTGGAGAA	CASSDRSGTGFPGELFF	In	VDJ	1	189	0.002329738058551618	0.0030587473701246155	51	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	3	6	8	4	23	36	53	44	57			01,02										Vb 1	CASSDRSGTGFPGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCGACTAGCGGAAATAATGAGCAGTTCTTCGGGCCA	CASSATSGNNEQFF	In	VDJ	1	203	0.00250231124807396	0.003285321249393106	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	2	5	7	1	4	23	36	46	37	50			01,02			01,02							Vb 1	CASSATSGNNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCAAAGGACCGGCGGACACTGAAGCTTTCTTTGGACAA	CASSKGPADTEAFF	In	VDJ	3	380	0.004684129429892141	0.006149862437287587	42	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	4	1	7	3	3	6	23	35	42	38	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSKGPADTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTATCCTGGTCTCAATTGTAAAACTCCTACGAGCAGTACGTCGGGCCG	CASSQVSWSQL*NSYEQYV	Stop	VDJ	1	44	5.423728813559322E-4		57	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	1	4	5	17	32	4	18	34	69	66	73				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQVSWSQL*NSYEQYV+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACCCAAATGGAATGAGCAGTTCTTCGGGCCA	CASSQPKWNEQFF	In	VDJ	1	171	0.0021078582434514636	0.002767438096779414	39	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	2	0	10	7	7	0	29	44	-1	51	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQPKWNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGCGACAGGGGATTTGCAGATACGCAGTATTTTGGCCCA	CASSQGDRGFADTQYF	In	VDJ	2	218	0.002687211093990755	0.0035280789771807734	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	2	2	4	2	5	29	45	55	47	60													Vb 16	CASSQGDRGFADTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTATCTGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	231	0.002847457627118644		46	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	5	5	29	41	50	46	55													Vb 16	X+TCRBV14-01+TCRBJ02-06	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGGAGTCAGGGATGGAACACTGAAGCTTTCTTTGGACAA	CASSRSQGWNTEAFF	In	VDJ	5	633	0.007802773497688752	0.010244376112639586	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	1	5	3	29	42	52	47	55													Vb 16	CASSRSQGWNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCACAGCAGGGGGCTGTTAACTGAAGCTTTCTTTGGACAA	CASSHSRGLLTEAFF	In	VDJ	6	855	0.010539291217257319	0.013837190483897071	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	0	5	3	5	29	43	54	46	59													Vb 16	CASSHSRGLLTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAGGGACTAGCGGGCCTTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	40	4.930662557781202E-4		50	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	1	4	3	0	4	24	-1	51	40	55						01,02								X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGATCGGCTAGCGGGGAAAGAGACCCAGTACTTCGGGCCA	CASSVDRLAGKETQYF	In	VDJ	1	82	0.0010107858243451463	0.0013270755785725846	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	4	3	3	9	1	24	36	54	45	55														CASSVDRLAGKETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGATGGGCTAGCGGGGGGCAGCACAGATACGCAGTATTTTGGCCCA	CASSVDGLAGGSTDTQYF	In	VDJ	1	147	0.0018120184899845916	0.0023790257323191453	54	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	1	0	9	1	24	36	56	45	57														CASSVDGLAGGSTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGGGGGGGCCCAAAACATTCAGTACTTCGGCGCC	CASGGAQNIQYF	In	VDJ	2	242	0.002983050847457627	0.003916491341641042	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	10	7	0	5	0	3	24	-1	40	31	43														CASGGAQNIQYF+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCCGGACTAGCGGAAAGCACAGATACGCAGTATTTTGGCCCA	CASSSGLAESTDTQYF	In	VDJ	1	75	9.244992295839754E-4	0.0012137886389383395	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	5	0	2	2	18	31	43	33	45						01,02								CASSSGLAESTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTATCGGACCACTTGGGGAGAGACCCAGTACTTCGGGCCA	CASSYRTTWGETQYF	In	VDJ	1	83	0.0010231124807395995	0.0013432594270917624	45	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-05	01	4	1	7	4	3	9	18	31	38	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRTTWGETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01		TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGGGACGAAGGTGGTGGAACCTACGAGCAGTACTTCGGGCCG	CASRDEGGGTYEQYF	In	VDJ	1	84	0.0010354391371340524	0.0013594432756109402	45	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-07	01	6	1	7	2	0	13	18	-1	33	29	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRDEGGGTYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01		TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCAGAGGGACAGGGGGCCGTGAAAAACTGTTTTTTGGCAGT	CASSRGTGGREKLFF	In	VDJ	1	39	4.807395993836672E-4	6.311700922479365E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	0	7	3	2	19	31	46	34	48													Vb 5.1	CASSRGTGGREKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACCTCCGGGACAGGGGCGCGTGAGCAGTTCTTCGGGCCA	CASTSGTGAREQFF	In	VDJ	1	46	5.670261941448382E-4	7.444570318821816E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	2	9	5	4	19	29	44	34	48													Vb 5.1	CASTSGTGAREQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCCCCAGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	51	6.286594761171033E-4		41	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	4	1	5	1	19	31	40	36	41													Vb 5.1	X+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCAGGGGTTAGGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	71	8.751926040061633E-4		44	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	1	0	6	19	-1	38	32	44													Vb 5.1	X+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCTATCCCGGGACTAGAAACAGATACGCAGTATTTTGGCCCA	CASSPIPGLETDTQYF	In	VDJ	1	87	0.0010724191063174115	0.0014079948211684738	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	8	3	8	2	19	31	47	39	49						01,02							Vb 5.1	CASSPIPGLETDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGCGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGGSSYNEQFF	In	VDJ	1	122	0.0015038520801232665	0.001974429519339699	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	7	2	0	0	0	19	-1	-1	35	42													Vb 5.1	CASSLGGSSYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTAGCGGGGGGGCGCCCAATGAGCAGTTCTTCGGGCCA	CASSFSGGAPNEQFF	In	VDJ	1	127	0.0015654853620955317	0.0020553487619355882	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	5	0	6	0	4	19	-1	44	33	48													Vb 5.1	CASSFSGGAPNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCGGAACGTCCTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	201	0.002477657935285054		49	TCRBV17	TCRBV17-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	1	6	5	8	5	22	33	46	41	51														X+TCRBV17-01+TCRBJ02-06	TCRBV17-01*01	TCRBD01-01*01	TCRBJ02-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCACTCAATGAGCAGTTCTTCGGGCCA	CASSLSLNEQFF	In	VDJ	1	52	6.409861325115563E-4	8.415601229972488E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	3	10	6	1	0	25	41	-1	42	45						01,02							Vb 3	CASSLSLNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGTCTGGGGGGGGAGGATTCACCCCTCCACTTTGGGAAC	CASSRLGGEDSPLHF	In	VDJ	1	56	6.902927580893683E-4	9.062955170739601E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	6	9	0	8	6	4	25	36	49	42	53													Vb 3	CASSRLGGEDSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCCCAGGGGTGGGGCCGGGATGGGGACATTCAGTACTTCGGCGCC	CASSAQGWGRDGDIQYF	In	VDJ	1	57	7.026194144838212E-4	9.22479365593138E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	4	2	8	3	16	25	37	46	40	62													Vb 3	CASSAQGWGRDGDIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTAAGACTAGCGGGAGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSLRLAGGTGELFF	In	VDJ	1	65	8.012326656394453E-4	0.001051950153746561	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	2	1	5	5	1	25	36	54	41	55													Vb 3	CASSLRLAGGTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTTGGGGGTTATAGTGATCAGCCCCAGCATTTTGGTGAT	CASSLFGGYSDQPQHF	In	VDJ	1	77	9.491525423728814E-4	0.0012461563359766952	48	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	1	6	1	5	2	8	25	41	48	43	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLFGGYSDQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGATCCAGTTCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	85	0.0010477657935285055		37	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	5	3	3	4	25	36	42	39	46													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAATTCCCCGGCAGTCAGAACTGAAGCTTTCTTTGGACAA	CASNSPAVRTEAFF	In	VDJ	1	95	0.0011710323574730353	0.0015374656093218968	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	7	4	5	5	9	5	25	35	47	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASNSPAVRTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTGGACCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSWTNTGELFF	In	VDJ	1	101	0.0012449922958397534	0.001634568700436964	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-02	01	6	1	7	2	2	1	25	36	42	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSWTNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01		TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGAGCCGGGACAGGGGAGGACAGATACGCAGTATTTTGGCCCA	CASSEPGQGRTDTQYF	In	VDJ	1	106	0.0013066255778120186	0.0017154879430328531	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	2	3	5	3	25	37	52	42	55													Vb 3	CASSEPGQGRTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTCGGCTCGGGATGGCTACACCTTCGGTTCG	CASSFSARDGYTF	In	VDJ	1	107	0.0013189522342064715	0.0017316717915520311	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	8	4	6	7	0	25	39	-1	46	50						01,02							Vb 3	CASSFSARDGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGCGGCAGGCGGCACTCTGGAAACACCATATATTTTGGAGAG	CASSGGRRHSGNTIYF	In	VDJ	1	111	0.0013682588597842835	0.0017964071856287425	48	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-03	01	5	4	4	0	5	5	25	37	46	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSGGRRHSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01		TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGGAATGAAAAACTGTTTTTTGGCAGT	CASSLGNEKLFF	In	VDJ	1	114	0.0014052388289676424	0.001844958731186276	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	3	6	2	5	0	0	25	-1	-1	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCTATAAGTCGGAGAGACCTACGAGCAGTACTTCGGGCCG	CASSPL*VGETYEQYF	Stop	VDJ	1	132	0.0016271186440677966		48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	2	2	12	3	25	37	53	49	56													Vb 3	CASSPL*VGETYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCACCGCGGGGCCAGAGTATACGAGCAGTACTTCGGGCCG	CASSHRGARVYEQYF	In	VDJ	1	135	0.0016640986132511557	0.002184819550089011	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	7	3	4	5	8	25	36	47	41	55													Vb 3	CASSHRGARVYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCACTAGCGGGAGCGGCGAATACGCAGTATTTTGGCCCA		Out	VDJ	1	138	0.0017010785824345146		46	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	3	2	7	2	6	25	38	51	40	57													Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTGTCCCGGATTCTCTGGAAACACCATATATTTTGGAGAG	CASCPGFSGNTIYF	In	VDJ	1	144	0.0017750385208012327	0.0023304741867616117	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-03	01	8	1	8	0	6	2	25	34	43	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASCPGFSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01		TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCAGGGAGTTGAAAAACTGTTTTTTGGCAGT	CASSFQGVEKLFF	In	VDJ	1	152	0.0018736517719568568	0.002459944974915035	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	3	4	3	7	1	3	25	39	45	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFQGVEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTRCCAGCAGTCTGACTAGCGCGGCCGGGGAGCTGTTTTTTGGAGAA	CXSSLTSAAGELFF	In	VDJ	2	254	0.0031309707241910633	0.0041106975238711764	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	2	6	6	2	3	25	37	47	39	50						01,02							Vb 3	CXSSLTSAAGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAGAACCGGGACTACCTACGAGCAGTACTTCGGGCCG	CASSRTGTTYEQYF	In	VDJ	2	254	0.0031309707241910633	0.0041106975238711764	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	9	2	6	0	25	37	-1	43	50						01,02							Vb 3	CASSRTGTTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACTCAGGGGGGGACTGTTTTTTGGCAGT	CASSLLRGGLFF	In	VDJ	3	436	0.00537442218798151	0.007056157954361547	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	2	4	1	13	2	2	25	40	49	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLLRGGLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCAAGCAGCCTGTCGGGTGAGCCCCAAGAGACCCAGTACTTCGGGCCA	CASSLSGEPQETQYF	In	VDJ	1	59	7.272727272727272E-4	9.548470626314937E-4	45	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	9	8	4	1	8	6	18	26	38	34	44						01,02								CASSLSGEPQETQYF+TCRBV12-02+TCRBJ02-05	TCRBV12-02*01	TCRBD02-01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCCCCCTAGCGGGGGTCCTCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	61	7.519260400616332E-4		47	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	2	5	3	5	18	30	43	33	48														X+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAACACAGGGCTTTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	39	4.807395993836672E-4		37	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	10	3	3	3	2	3	22	29	37	31	40														X+TCRBV07-04+TCRBJ01-03	TCRBV07-04*01	TCRBD01-01*01	TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCGACCCCGGGGCCCTCCTCCTACGAGCAGTACTTCGGGCCG	CASTPGPSSYEQYF	In	VDJ	1	50	6.163328197226503E-4	8.091924259588931E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	7	7	0	0	7	4	26	33	45	40	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CASTPGPSSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCAACACAGCACAGATACGCAGTATTTTGGCCCA	CAWSQHSTDTQYF	In	VDJ	1	58	7.149460708782742E-4	9.386632141123159E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	3	6	0	2	1	26	38	43	40	44													Vb 20	CAWSQHSTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCAACTCCAACCCAACTAATGAAAAACTGTTTTTTGGCAGT	CAWSVNSNPTNEKLFF	In	VDJ	1	58	7.149460708782742E-4	9.386632141123159E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	3	10	0	2	6	26	40	45	42	51						01,02							Vb 20	CAWSVNSNPTNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD02-01	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCCTCGGAGGGTCCTACACCTTCGGTTCG	CAWSVLGGSYTF	In	VDJ	1	61	7.519260400616332E-4	9.872147596698495E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	10	0	10	4	2	26	40	50	44	52			unresolved										Vb 20	CAWSVLGGSYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCGGGGGCCTTGAAGCTTTCTTTGGACAA	CAWSPGGLEAFF	In	VDJ	1	99	0.0012203389830508474	0.0016022010033986081	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	2	6	0	7	3	2	26	38	47	41	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSPGGLEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCTCTGTGCCTGGAGTACTTACTGGACAGGGGGCGTCCCCGTTCTCTGGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	119	0.0014668721109399076		65	TCRBV30	TCRBV30-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	1	0	4	7	14	5	17	35	24	49			01,02										Vb 20	X+TCRBV30-01+TCRBJ02-06	TCRBV30-01	TCRBD01-01*01	TCRBJ02-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGATCAACGGGGAGGCTACACCTTCGGTTCG	CAWDQRGGYTF	In	VDJ	1	135	0.0016640986132511557	0.002184819550089011	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	3	8	6	1	26	35	46	41	47													Vb 20	CAWDQRGGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCTAAGGAGTCTCGCTAATTCACCCCTCCACTTTGGGAAC	CAWTLRSLANSPLHF	In	VDJ	1	183	0.0022557781201848997	0.0029616442790095484	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	4	10	2	6	6	6	26	36	46	42	52			unresolved										Vb 20	CAWTLRSLANSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGGGTCTGAAGCTTTCTTTGGACAA	CAWSVGSEAFF	In	VDJ	1	198	0.0024406779661016948	0.0032044020067972163	33	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	0	5	3	6	0	1	26	-1	44	40	45			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVGSEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATCGGTCAAGCCCCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	2	305	0.0037596302003081662		40	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	4	4	5	17	21	4	26	36	60	57	64				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTGGATCCCTAGCGAATGAGCAGTTCTTCGGGCCA	CAWSVGSLANEQFF	In	VDJ	2	306	0.0037719568567026194	0.004952257646868425	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	6	7	7	0	26	40	-1	47	53						01,02							Vb 20	CAWSVGSLANEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTAGGACTAGCGGATACGAGCAGTACTTCGGGCCG	CAWTRTSGYEQYF	In	VDJ	2	321	0.003956856702619415	0.005195015374656093	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	1	5	4	3	1	26	36	49	39	50			unresolved			01,02							Vb 20	CAWTRTSGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTACGCCGGGACTAGTAAGTACGAGCAGTACTTCGGGCCG	CAYAGTSKYEQYF	In	VDJ	4	508	0.006261941448382127	0.008221395047742353	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	8	4	5	4	26	33	46	38	50			unresolved			01,02							Vb 20	CAYAGTSKYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTAAGACAGACCTCGAACACTGAAGCTTTCTTTGGACAA	CAWSLRQTSNTEAFF	In	VDJ	4	508	0.006261941448382127	0.008221395047742353	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	5	1	4	5	26	38	47	42	52			unresolved										Vb 20	CAWSLRQTSNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTCCAATGGACTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSLQWTSGSTDTQYF	In	VDJ	1	41	5.053929121725732E-4	6.635377892862923E-4	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	4	0	6	0	23	36	-1	42	53						01,02								CASSLQWTSGSTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCACCTCACCCGGACAGAGTAACTATGGCTACACCTTCGGTTCG	CASTSPGQSNYGYTF	In	VDJ	1	105	0.0012942989214175654	0.0016993040945136753	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	5	1	8	2	23	33	47	41	49														CASTSPGQSNYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAATCTAGGGGACAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQSRGQGNTGELFF	In	VDJ	1	105	0.0012942989214175654	0.0016993040945136753	51	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	3	1	5	0	23	38	-1	43	52														CASSQSRGQGNTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCGGGACAGGGGGCCATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	166	0.002046224961479199		41	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	0	8	1	1	23	36	49	37	50														X+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACCGGACACCAGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSVEPDTRSSYNEQFF	In	VDJ	1	46	5.670261941448382E-4	7.444570318821816E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	6	0	2	7	25	37	44	39	51													Vb 4	CSVEPDTRSSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATAGGTGGCCAAGGGCTTTCTTTGGACAA	CSVEDRWPRAFF	In	VDJ	1	65	8.012326656394453E-4	0.001051950153746561	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	0	5	4	11	1	9	25	39	43	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEDRWPRAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGATTGACAGGCTGGGCTGAAGCTTTCTTTGGACAA	CSGLTGWAEAFF	In	VDJ	1	70	8.628659476117103E-4	0.0011328693963424503	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	4	6	4	5	25	32	42	36	47													Vb 4	CSGLTGWAEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCATGGAACCTCGGGAAACACCATATATTTTGGAGAG	CSVHGTSGNTIYF	In	VDJ	1	99	0.0012203389830508474	0.0016022010033986081	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-03	01	5	1	8	4	3	6	25	34	40	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVHGTSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01		TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTAGACCGCGATGGACCCCAGCATTTTGGTGAT	CSVVDRDGPQHF	In	VDJ	1	99	0.0012203389830508474	0.0016022010033986081	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	0	1	8	10	7	0	25	39	-1	46	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVDRDGPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCTATAGACAGGGACTCTATGGCTACACCTTCGGTTCG	CSYRQGLYGYTF	In	VDJ	1	102	0.0012573189522342065	0.0016507525489561417	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	2	3	4	4	3	25	31	42	35	45													Vb 4	CSYRQGLYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCCCCCGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVEDPPGSGANVLTF	In	VDJ	1	107	0.0013189522342064715	0.0017316717915520311	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	0	8	4	0	5	0	25	39	-1	44	48						01,02							Vb 4	CSVEDPPGSGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD02-01	TCRBJ02-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTTCTCGGCAGGGCATATCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVFSAGHISGANVLTF	In	VDJ	1	119	0.0014668721109399076	0.0019258779737821655	51	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	4	3	0	7	5	25	34	46	41	51													Vb 4	CSVFSAGHISGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGGGGGGGGGAAGAGACCCAGTACTTCGGGCCA	CSVRGGEETQYF	In	VDJ	1	121	0.0014915254237288136	0.001958245670820521	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	0	3	0	2	25	-1	42	34	44													Vb 4	CSVRGGEETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTACCCTAGGGGGAAACACCATATATTTTGGAGAG	CSATLGGNTIYF	In	VDJ	1	127	0.0015654853620955317	0.0020553487619355882	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-03	01	7	5	3	4	7	0	25	32	-1	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSATLGGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01		TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGTTGGGGGGAAACCGGGGAGCTGTTTTTTGGAGAA	CSVGWGETGELFF	In	VDJ	1	134	0.0016517719568567026	0.0021686357015698334	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	9	1	5	3	2	25	35	44	38	46													Vb 4	CSVGWGETGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAACCGTGGACAGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVETVDRGNTGELFF	In	VDJ	1	148	0.0018243451463790447	0.0023952095808383233	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	2	1	5	0	25	37	-1	42	51													Vb 4	CSVETVDRGNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCGGGGCACAGATACGCAGTATTTTGGCCCA	CSVEDRGTDTQYF	In	VDJ	1	155	0.0019106317411402157	0.0025084965204725685	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	8	4	1	1	0	25	39	-1	40	44						01,02							Vb 4	CSVEDRGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCCAACTCAACCCCCGAGGACTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	157	0.0019352850539291217		44	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	1	9	17	17	11	25	33	56	50	67						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCTCACCGACGGGGGATACGCAGTATTTTGGCCCA	CSVSPTGDTQYF	In	VDJ	2	214	0.002637904468412943	0.0034633435831040622	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	3	6	8	0	25	33	-1	41	46													Vb 4	CSVSPTGDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGCCGGGACATTCCACCGGGGAGCTGTTTTTTGGAGAA	CSVPGHSTGELFF	In	VDJ	2	215	0.002650231124807396	0.00347952743162324	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	6	4	3	3	25	33	42	36	45													Vb 4	CSVPGHSTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGCCAGGGACAGGGAACTGAAGCTTTCTTTGGACAA	CSGQGQGTEAFF	In	VDJ	2	216	0.002662557781201849	0.003495711280142418	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	3	5	4	1	25	32	45	36	46													Vb 4	CSGQGQGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACCAGGGGGATAATTCACCCCTCCACTTTGGGAAC	CSVDQGDNSPLHF	In	VDJ	2	228	0.002810477657935285	0.003689917462372552	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	4	1	5	1	0	25	36	-1	37	44													Vb 4	CSVDQGDNSPLHF+TCRBV29-01+TCRBJ01-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTAAAGGGGTGGATTAGCACAGATACGCAGTATTTTGGCCCA	CSVVKGWISTDTQYF	In	VDJ	2	241	0.002970724191063174	0.0039003074931218645	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	5	2	0	3	6	25	35	43	38	49													Vb 4	CSVVKGWISTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGCTAATCAGGGACTAGCGGGGAGGATTTAACGTTGAGCAGTTCTTCGGGCCA		Out	VDJ	2	305	0.0037596302003081662		59	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	0	3	9	8	12	22	35	56	43	68													Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGGGAGGACGGAAGGTCATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	7	925	0.01140215716486903		37	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	9	10	1	6	0	10	25	-1	35	30	45													Vb 4	X+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCCGTATAAGCGGGAGGTAAATCTGGGAGAGCAGTTCTTTGGGCCA	CASSPYKREVNLGEQFF	In	VDJ	1	84	0.0010354391371340524	0.0013594432756109402	51	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02			5	6	1	22	7	23	22	34	50	41	73								TCRBJ02-01,TCRBJ02-05						CASSPYKREVNLGEQFF+TCRBV07-01+TCRBJ02-X	TCRBV07-01*01	TCRBD02-01*02	TCRBJ02	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGGGGCTAGCGGGAGCGATGAGCAGTTCTTCGGGCCA	CASSLGASGSDEQFF	In	VDJ	1	145	0.0017873651771956856	0.0023466580352807897	45	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	4	2	8	6	2	22	35	51	41	53														CASSLGASGSDEQFF+TCRBV07-01+TCRBJ02-01	TCRBV07-01*01	TCRBD02-01*02	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGACAGGGTCCCGAACGGGCCCCCAGCATTTTGGTGAT		Out	VDJ	1	92	0.0011340523882896764		43	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	10	0	12	23	-1	42	37	54													Vb 12	X+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCGGGCGAGACAGACTAAACACCGGGGAGCTGTTTTTTGGAGAA	CAGRDRLNTGELFF	In	VDJ	1	39	4.807395993836672E-4	6.311700922479365E-4	42	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-02	01	11	2	5	2	6	4	24	30	41	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAGRDRLNTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01		TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGAAGGGGAACACTGAAGCTTTCTTTGGACAA	CAISEKGNTEAFF	In	VDJ	1	50	6.163328197226503E-4	8.091924259588931E-4	39	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-01	01	2	5	3	1	1	0	23	38	-1	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISEKGNTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGTATCAGGGAGCTGGAAACACCATATATTTTGGAGAG	CAISESYQGAGNTIYF	In	VDJ	1	162	0.001996918335901387	0.0026217834601068133	48	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-03	01	0	4	3	2	4	2	23	40	49	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESYQGAGNTIYF+TCRBV10-03+TCRBJ01-03	TCRBV10-03*01		TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGCAGGATTAACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSIAGLTGANVLTF	In	VDJ	1	39	4.807395993836672E-4	6.311700922479365E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	4	4	2	2	5	27	41	47	43	52			01,02										Vb 17	CASSIAGLTGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTCGACAGGGACTGCTTTCTTTGGACAA	CASTSTGTAFF	In	VDJ	1	43	5.300462249614792E-4	6.95905486324648E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	3	11	4	3	27	37	48	41	51			01,02										Vb 17	CASTSTGTAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGACAGCCATATCAATCAGCCCCAGCATTTTGGTGAT	CASRDSHINQPQHF	In	VDJ	1	43	5.300462249614792E-4	6.95905486324648E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	5	3	0	6	27	-1	44	38	50			01,02										Vb 17	CASRDSHINQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCGCGCGGGGGGACTACAATGAGCAGTTCTTCGGGCCA	CASSSARGDYNEQFF	In	VDJ	1	43	5.300462249614792E-4	6.95905486324648E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	1	3	5	1	27	39	52	44	53			01,02										Vb 17	CASSSARGDYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAGCTTTCTATCTCTGTGCCAGTAGTTTCGTTTCCGGGACAGGGGCTTCCCATCGTGGAAACACCATATATTTTGGAGAG	CASSFVSGTGASHRGNTIYF	In	VDJ	1	52	6.409861325115563E-4	8.415601229972488E-4	60	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	2	3	9	10	14	26	45	35	55			01,02										Vb 17	CASSFVSGTGASHRGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACACGGGACGTCGGAAACACCATATATTTTGGAGAG	CATRDVGNTIYF	In	VDJ	1	55	6.779661016949153E-4	8.901116685547824E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	10	0	7	4	3	3	27	34	42	37	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CATRDVGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACCAGGGGGTATGGCAGCCCCAGCATTTTGGTGAT	CASSIDQGVWQPQHF	In	VDJ	1	55	6.779661016949153E-4	8.901116685547824E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	1	7	1	5	27	44	52	45	57			01,02										Vb 17	CASSIDQGVWQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGACTAACGGCGGGCGGGGAGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	57	7.026194144838212E-4		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	9	7	3	5	11	2	27	35	52	46	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGGGCGAGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSWASNTGELFF	In	VDJ	1	77	9.491525423728814E-4	0.0012461563359766952	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	8	0	2	1	4	27	39	44	40	48			01,02										Vb 17	CASSWASNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATACAGCGAGGGAAATGAGCAGTTCTTCGGGCCA	CASSIYSEGNEQFF	In	VDJ	1	80	9.861325115562403E-4	0.0012947078815342288	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	11	0	7	6	1	27	42	53	48	54			01,02										Vb 17	CASSIYSEGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTGTAAGCGCAAATCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	91	0.0011217257318952233		55	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	6	6	5	5	14	26	38	47	43	61			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD02-01	TCRBJ02-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGCCGTGGGATTGAACTACGAGCAGTACTTCGGGCCG	CASAVGLNYEQYF	In	VDJ	1	97	0.0011956856702619414	0.0015698333063602526	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	9	0	8	3	6	5	27	35	45	41	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASAVGLNYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTCAGGACAGGGTCAAAGCTAACTATGGCTACACCTTCGGTTCG	CATQDRVKANYGYTF	In	VDJ	1	99	0.0012203389830508474	0.0016022010033986081	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	1	3	0	4	6	27	34	46	38	52			01,02										Vb 17	CATQDRVKANYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTGGGGACAGCCTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSMWGQPYSNQPQHF	In	VDJ	1	100	0.0012326656394453005	0.0016183848519177862	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	5	0	3	5	27	41	51	44	56			01,02										Vb 17	CASSMWGQPYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTACAGGGGGGGAATAATTCACCCCTCCACTTTGGGAAC	CASSLQGGNNSPLHF	In	VDJ	1	104	0.0012819722650231125	0.0016831202459944975	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	1	5	3	3	27	38	49	41	52			01,02										Vb 17	CASSLQGGNNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCGTAGAGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSPRRGGTDTQYF	In	VDJ	1	116	0.0014298921417565484	0.0018773264282246319	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	5	5	1	3	8	1	27	39	53	47	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPRRGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTGGGGCGGGGGTCAGCCCCAGCATTTTGGTGAT	CASTWGGGQPQHF	In	VDJ	1	124	0.0015285053929121725	0.0020067972163780546	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	7	7	2	6	6	0	27	37	-1	43	50			01,02										Vb 17	CASTWGGGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGCGCAGCATATCAGCCCCAGCATTTTGGTGAT	CASSIGGAAYQPQHF	In	VDJ	1	127	0.0015654853620955317	0.0020553487619355882	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	7	0	5	0	7	27	-1	48	43	55			01,02										Vb 17	CASSIGGAAYQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCGTTCTTGGAGGGGCGAAGACCGGGGAGCTGTTTTTTGGAGAA	CASTVLGGAKTGELFF	In	VDJ	1	128	0.0015778120184899846	0.0020715326104547662	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	10	0	5	8	6	27	37	51	45	57			01,02										Vb 17	CASTVLGGAKTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAGTCCGGGACTAGACCGTTCCACAACATTCAGTACTTCGGCGCC	CASSQSGTRPFHNIQYF	In	VDJ	1	141	0.0017380585516178736	0.002281922641204078	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	0	8	7	6	10	27	39	53	45	63			01,02			01,02							Vb 17	CASSQSGTRPFHNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01	TCRBJ02-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCTTTGGGAAAACGAGTGCTACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	146	0.0017996918335901387		56	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	1	0	8	0	5	11	25	41	50	46	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAAGGGGTCTCTTATAACAAGGGCTTTCTTTGGACAA	CASSIKGSLITRAFF	In	VDJ	1	151	0.0018613251155624037	0.002443761126395857	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	5	2	11	2	15	27	41	48	43	63			01,02										Vb 17	CASSIKGSLITRAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGACAGGGTGGAATCACTGAAGCTTTCTTTGGACAA	CASSMGQGGITEAFF	In	VDJ	1	157	0.0019352850539291217	0.002540864217510924	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	4	0	6	27	-1	50	41	56			01,02										Vb 17	CASSMGQGGITEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAACAGGGGGCAAGGGCTGGCTACACCTTCGGTTCG	CASSEQGARAGYTF	In	VDJ	1	159	0.001959938366718028	0.0025732319145492797	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	0	7	2	6	27	39	50	41	56			01,02										Vb 17	CASSEQGARAGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCGACGGATCACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	169	0.002083204930662558		44	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	6	1	8	0	5	3	27	38	46	43	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGTCAGGGCAACTACGAGCAGTACGTCGGGCCG	CASSIGQGNYEQYV	In	VDJ	1	172	0.0021201848998459167	0.002783621945298592	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	3	17	2	17	27	43	50	45	67			01,02										Vb 17	CASSIGQGNYEQYV+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTATAGGGCAGGCACAGATACGCAGTATTTTGGCCCA	CASSIYRAGTDTQYF	In	VDJ	1	172	0.0021201848998459167	0.002783621945298592	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	3	5	3	1	4	3	27	41	49	45	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIYRAGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGACAGGGGGGTAAGCCCCAGTATTTTGGTGAT		Out	VDJ	1	182	0.0022434514637904466		40	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	1	17	0	12	27	-1	50	41	62			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTGGGGCCAGCGGGAACGTTTGCTAATGAGCAGTTCTTCGGGCCA	CASSLGPAGTFANEQFF	In	VDJ	2	219	0.002699537750385208	0.0035442628256999514	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	3	7	8	9	27	39	54	47	63			01,02										Vb 17	CASSLGPAGTFANEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTATGGGGAATGAGCAGTTCTTCGGGCCA	CASSIMGNEQFF	In	VDJ	2	226	0.002785824345146379	0.0036575497653341966	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	3	6	2	7	3	0	27	41	-1	44	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIMGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGCGAGCAGTACTTCGGGCCG	CASSIGGEQYF	In	VDJ	2	228	0.002810477657935285	0.003689917462372552	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	1	6	2	6	0	0	27	-1	-1	43	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGGTCAACTAATGAAAAACTGTTTTTTGGCAGT	CARSTNEKLFF	In	VJ	3	349	0.004302003081664099	0.005648163133193073	33	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	9	0	0	0	0	2	27	-1	35	-1	37			01,02										Vb 17	CARSTNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCACCCCTTCCCTCAGAGACCCAGTACTTCGGGCCA	CASSISPLPSETQYF	In	VDJ	3	360	0.004437596302003082	0.0058261854669040295	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	2	3	7	4	2	10	27	42	46	44	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSISPLPSETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSINTGELFF	In	VJ	4	541	0.006668721109399076	0.008755462048875222	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	3	0	0	2	0	1	27	-1	41	-1	42			01,02										Vb 17	CASSINTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCTCGGGACAGGAGAGCAGTACTTCGGGCCG	CASSILGTGEQYF	In	VDJ	16	2263	0.02789522342064715	0.0366240491988995	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	4	7	4	1	27	41	53	45	54			01,02										Vb 17	CASSILGTGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAGGTGGGGTCGGACTATGGCTACACCTTCGGTTCG	CASSEVGSDYGYTF	In	VDJ	1	146	0.0017996918335901387	0.0023628418837999677	42	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-02	01	3	6	2	3	3	4	23	37	44	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSEVGSDYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01		TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCAGGTTGAGGACACTGAAGCTTTCTTTGGACAA	CASSQVEDTEAFF	In	VDJ	1	149	0.0018366718027734976	0.0024113934293575013	39	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	5	4	4	3	0	6	23	-1	39	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSQVEDTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGTCCCGGGACTAGCGGGAGGTGGAGAGCAGTACTTCGGGCCG	CASSVPGLAGGGEQYF	In	VDJ	1	171	0.0021078582434514636	0.002767438096779414	48	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	0	1	7	4	4	23	36	55	40	59													Vb 11	CASSVPGLAGGGEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTTGCGTTTGAACAGGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	184	0.002268104776579353		47	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	4	0	9	2	23	35	49	44	51													Vb 11	X+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTAGTGTACGGGGTCCGACCTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLVYGVRPATNEKLFF	In	VDJ	1	44	5.423728813559322E-4	7.120893348438259E-4	57	TCRBV11	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	1	8	3	0	4	9	18	34	43	38	52		TCRBV11-01,TCRBV11-03												CASSLVYGVRPATNEKLFF+TCRBV11-X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTGGACAGGAGTTATAAAAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	50	6.163328197226503E-4		49	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	4	2	0	10	18	-1	39	32	49		TCRBV11-01,TCRBV11-03												X+TCRBV11-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTCAGGGGCTTCCGATACGCAGTATTTTGGCCCA	CASSSGASDTQYF	In	VDJ	1	51	6.286594761171033E-4	8.253762744780709E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	2	6	0	5	18	-1	37	31	42		TCRBV07-01,TCRBV07-02												CASSSGASDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCYAGCAGTACGATCGGGGAGCAGTACTTCGGGCCG	CASSTIGEQYF	In	VDJ	1	53	6.533127889060093E-4	8.577439715164266E-4	33	TCRBV12	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	9	8	4	7	9	0	26	34	-1	43	47		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSTIGEQYF+TCRBV12-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGGCTTGAGAGCAGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	59	7.272727272727272E-4		37	TCRBV10	unresolved					TCRBJ01	TCRBJ01-01	01	6	4	5	6	9	0	23	34	-1	43	46		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTGCAGGGACAGGGGATAAACTACGAGCAGTACTTCGGGCCG	CASSLQGQGINYEQYF	In	VDJ	1	59	7.272727272727272E-4	9.548470626314937E-4	48	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	3	3	5	19	33	46	36	51		TCRBV11-01,TCRBV11-03												CASSLQGQGINYEQYF+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTCAATGAAGACAGGGCTGGGCGAAAAACTGTTTTTTGGCAGT	CASSSMKTGLGEKLFF	In	VDJ	1	61	7.519260400616332E-4	9.872147596698495E-4	48	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	3	8	7	6	18	31	45	38	51		TCRBV11-01,TCRBV11-03												CASSSMKTGLGEKLFF+TCRBV11-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGAGCGGGCCTCACCGGGACGCAGTATTTTGGCCCA	CASRAGLTGTQYF	In	VDJ	1	71	8.751926040061633E-4	0.001149053244861628	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	6	4	9	0	10	22	-1	39	33	49		TCRBV07-01,TCRBV07-04				01,02								CASRAGLTGTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCGGGACCGCCAAGAGACCCAGTACTTCGGGCCA	CASSRDRQETQYF	In	VDJ	1	72	8.875192604006164E-4	0.0011652370933808059	39	TCRBV06	unresolved					TCRBJ02	TCRBJ02-05	01	5	0	7	1	1	2	23	35	41	36	43		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDRQETQYF+TCRBV06-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCCCCGGAGGAGGGGGCAAAAACATTCAGTACTTCGGCGCC	CASSPGGGGKNIQYF	In	VDJ	1	72	8.875192604006164E-4	0.0011652370933808059	45	TCRBV07	unresolved					TCRBJ02	TCRBJ02-04	01	4	5	1	3	8	0	19	31	-1	39	45		TCRBV07-05,TCRBV07-06		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGGGGKNIQYF+TCRBV07-X+TCRBJ02-04	unresolved		TCRBJ02-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCACCCTGACAGGGGCAATTAGCTATGGCTACACCTTCGGTTCG	CATLTGAISYGYTF	In	VDJ	1	89	0.0010970724191063175	0.0014403625182068296	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	2	2	4	4	7	23	30	42	34	49		TCRBV06-07,TCRBV06-08												CATLTGAISYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGATAGAGCGGACAGGGTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	93	0.0011463790446841293		46	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	3	3	6	1	26	40	54	46	55		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTGGACGGACCCGTTTTCCACCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	112	0.0013805855161787366		53	TCRBV07	unresolved					TCRBJ01	TCRBJ01-01	01	4	1	7	1	1	16	22	35	40	36	56		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTACCGGACAGGAGTTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSTGQELNTGELFF	In	VDJ	1	163	0.0020092449922958396	0.0026379673086259913	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	4	1	3	4	23	35	45	38	49		TCRBV06-07,TCRBV06-08												CASSTGQELNTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAGCAGGTGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSEQVSSYEQYF	In	VDJ	1	87	0.0010724191063174115	0.0014079948211684738	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	4	0	1	4	23	37	42	38	46													Vb 22	CASSEQVSSYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCTAAACCGGGACCCTGATACGCAGTATTTTGGCCCA	CASSLNRDPDTQYF	In	VDJ	1	199	0.002453004622496148	0.0032205858553163943	42	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-03	01	5	0	7	6	7	3	23	35	47	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSLNRDPDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01		TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCATCAGTGAAATGGATACGCAGTATTTTGGCCCA	CAISEMDTQYF	In	VJ	1	40	4.930662557781202E-4	6.473539407671144E-4	33	TCRBV06	TCRBV06-04					TCRBJ02	TCRBJ02-03	01	3	0	0	6	0	4	28	-1	42	-1	46			01,02											CAISEMDTQYF+TCRBV06-04+TCRBJ02-03	TCRBV06-04		TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTATATCGCTGCGTATTTACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	49	6.040061633281972E-4		55	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-06	01	5	3	6	5	16	4	26	38	57	54	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ02-06	TCRBV06-07*01		TCRBJ02-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGGACAATCGGAAAACTGTTTTTTGGCAGT	CASRTIGKLFF	In	VDJ	1	159	0.001959938366718028	0.0025732319145492797	33	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	6	10	0	5	26	-1	41	37	46														CASRTIGKLFF+TCRBV06-07+TCRBJ01-04	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCCGAACATGGTCGACCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	177	0.002181818181818182		44	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-07	01	5	2	7	17	12	15	26	38	53	50	68				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01		TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTAGGAGCAGGGAAGATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	186	0.0022927580893682587		49	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	4	3	5	5	3	26	42	52	47	55														X+TCRBV06-07+TCRBJ01-06	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCTCAACGGGGCCAGGCAACGCTCTGGAAACACCATATATTTTGGAGAG	CASSLNGARQRSGNTIYF	In	VDJ	1	50	6.163328197226503E-4	8.091924259588931E-4	54	TCRBV07	TCRBV07-07	01				TCRBJ01	TCRBJ01-03	01	5	7	0	0	6	9	19	31	42	37	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNGARQRSGNTIYF+TCRBV07-07+TCRBJ01-03	TCRBV07-07*01		TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAGGACAACCGGGACACCCGGCTTACGAGCAGTACTTCGGGCCG	CASSLGQPGHPAYEQYF	In	VDJ	1	56	6.902927580893683E-4	9.062955170739601E-4	51	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	6	4	7	7	19	35	48	42	55														CASSLGQPGHPAYEQYF+TCRBV07-07+TCRBJ02-07	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CACCAGCCAAACAGCTTTGTACTTCTGTCCTGGGAGCTACTAAAGGAAGCGAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	147	0.0018120184899845916		55	TCRBV22	TCRBV22-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	4	3	9	5	1	18	25	37	42	38	60						01,02								X+TCRBV22-01+TCRBJ02-06	TCRBV22-01*01	TCRBD02-01	TCRBJ02-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCACCCCGGACTAGCGGGAGTGGTTAAGGAATGAGCAGTTCTTCGGGCCA	CASTPD*REWLRNEQFF	Stop	VDJ	1	40	4.930662557781202E-4		51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	1	2	7	4	9	19	29	46	33	55	TCRBV05,TCRBV07													CASTPD*REWLRNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTACCCTGGGGGCTCCGGAAACACCATATATTTTGGAGAG	CASSYPGGSGNTIYF	In	VDJ	1	41	5.053929121725732E-4	6.635377892862923E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	6	0	4	5	3	22	35	46	40	49	TCRBV07,TCRBV11													CASSYPGGSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAAGGGGGGGGAGGACTATGGCTACACCTTCGGTTCG	CSARKGGEDYGYTF	In	VDJ	1	42	5.177195685670262E-4	6.797216378054701E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	9	0	3	2	4	26	38	47	40	51		TCRBV20-01,TCRBV20-or09_02												CSARKGGEDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ACCAGACAGCTCTTTACTTCTGTGCCACTCCTTTGAACACAGGGACAATAGAGAAATCCAGTTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	43	5.300462249614792E-4		61	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	0	6	1	13	15	20	28	47	41	62		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATCTCTGTGGCAGAGAAATTCACCCCTCCACTTTGGGAAC	CASSLSLWQRNSPLHF	In	VDJ	1	43	5.300462249614792E-4	6.95905486324648E-4	48	unresolved						TCRBJ01	TCRBJ01-06	01	0	4	5	7	7	3	23	40	50	47	53	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSLWQRNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATCCCTAGCGGGGGATCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	43	5.300462249614792E-4		46	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	4	2	6	3	2	23	38	51	41	53		TCRBV06-01,TCRBV06-08												X+TCRBV06-X+TCRBJ02-01	TCRBV06	TCRBD02-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTAAATGGAAAGGGAGTGAAAAACTGTTTTTTGGCAGT	CASSKWKGSEKLFF	In	VDJ	1	43	5.300462249614792E-4	6.95905486324648E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	9	2	7	10	0	23	34	-1	44	49	TCRBV02,TCRBV09													CASSKWKGSEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGCACCACTCCATTTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	45	5.546995377503852E-4		50	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	2	7	4	19	0	26	38	-1	57	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCATCGGGGCCACAGATACGCAGTATTTTGGCCCA	CASSFIGATDTQYF	In	VDJ	1	46	5.670261941448382E-4	7.444570318821816E-4	42	TCRBV12						TCRBJ02	TCRBJ02-03	01	3	7	0	2	4	0	26	40	-1	44	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFIGATDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGATATGGTACCCCGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSQDMVPRGTGELFF	In	VDJ	1	47	5.793528505392912E-4	7.606408804013595E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	8	3	4	10	0	23	40	-1	50	55	TCRBV01,TCRBV23													CASSQDMVPRGTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCATCGCGAGACTCCCCTACGAGCAGTACTTCGGGCCG	CAIARLPYEQYF	In	VDJ	1	47	5.793528505392912E-4	7.606408804013595E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	9	2	10	2	6	2	23	30	40	36	42	TCRBV02,TCRBV09					01,02								CAIARLPYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGCCGGGACAGGGCTTTACGAGCAGTACTTCGGGCCG	CASAGTGLYEQYF	In	VDJ	1	48	5.916795069337442E-4	7.768247289205373E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	0	3	4	5	3	24	31	45	36	48		TCRBV24-01,TCRBV24-or09_02												CASAGTGLYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACTTGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSELGGNTEAFF	In	VDJ	1	49	6.040061633281972E-4	7.930085774397152E-4	42	TCRBV06						TCRBJ01	TCRBJ01-01	01	2	6	1	1	3	0	23	38	-1	41	46		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSELGGNTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCTCGGGGGGATAGCGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGGIAAYNEQFF	In	VDJ	1	50	6.163328197226503E-4	8.091924259588931E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	1	2	3	7	26	37	47	40	54		TCRBV03-01,TCRBV03-02												CASSLGGIAAYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACTCCGGGACAGTTCAGGGCTACACCTTCGGTTCG	CSARDSGTVQGYTF	In	VDJ	1	50	6.163328197226503E-4	8.091924259588931E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	5	8	4	5	26	40	51	44	56		TCRBV20-01,TCRBV20-or09_02												CSARDSGTVQGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTGCAGGGTTAGACTATGGCTACACCTTCGGTTCG	CSARVAGLDYGYTF	In	VDJ	1	53	6.533127889060093E-4	8.577439715164266E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	3	3	3	4	26	39	47	42	51		TCRBV20-01,TCRBV20-or09_02												CSARVAGLDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATGGCAGGGACCGGTGAAAAACTGTTTTTTGGCAGT	CSARDMAGTGEKLFF	In	VDJ	1	54	6.656394453004623E-4	8.739278200356045E-4	45	TCRBV20						TCRBJ01	TCRBJ01-04	01	0	0	7	7	7	3	26	40	52	47	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDMAGTGEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCCAGGGGTGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQGWNTGELFF	In	VDJ	1	54	6.656394453004623E-4	8.739278200356045E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	2	1	1	2	23	34	41	35	43	TCRBV24,TCRBV27													CASSQGWNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGGACAGGGTGAGGTCTGGAAACACCATATATTTTGGAGAG	CASSLDRVRSGNTIYF	In	VDJ	1	54	6.656394453004623E-4	8.739278200356045E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	1	3	1	0	5	19	-1	41	33	46	TCRBV07,TCRBV11													CASSLDRVRSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGAGGGACTAGCGGTTACAATGAGCAGTTCTTCGGGCCA	CSARGGTSGYNEQFF	In	VDJ	1	55	6.779661016949153E-4	8.901116685547824E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	5	4	4	1	26	37	52	41	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGGTSGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACAGGGACAGGGGGGACACGGAGAGACTTCGGCGCC	CASTGTGGTRRDF	In	VDJ	1	55	6.779661016949153E-4	8.901116685547824E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	0	1	17	2	11	22	32	45	34	56		TCRBV12-03,TCRBV12-04												CASTGTGGTRRDF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD01-01*01	TCRBJ02-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCTCCCGACAGGGCACTGAAGCTTTCTTTGGACAA	CASSSRQGTEAFF	In	VDJ	1	56	6.902927580893683E-4	9.062955170739601E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	3	4	5	0	22	33	-1	38	45		TCRBV12-03,TCRBV12-04												CASSSRQGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCATCGGACTAGCGGGAGCAGATACGCAGTATTTTGGCCCA	CAIGLAGADTQYF	In	VDJ	1	56	6.902927580893683E-4	9.062955170739601E-4	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	11	1	2	4	2	0	24	31	-1	33	46		TCRBV24-01,TCRBV24-or09_02												CAIGLAGADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACTACTTGGGGGCAGGGTGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	56	6.902927580893683E-4		49	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	6	0	4	6	7	23	38	50	44	57		TCRBV06-01,TCRBV06-08												X+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCAGGACAGGGAGGTAATTCACCCCTCCACTTTGGGAAC	CASSPGQGGNSPLHF	In	VDJ	1	57	7.026194144838212E-4	9.22479365593138E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	3	6	3	3	26	38	49	41	52		TCRBV12-03,TCRBV12-04												CASSPGQGGNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGGCCGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQEGPGANVLTF	In	VDJ	1	57	7.026194144838212E-4	9.22479365593138E-4	45	TCRBV03						TCRBJ02	TCRBJ02-06	01	0	5	3	4	0	3	26	-1	47	43	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGPGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03		TCRBJ02-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCTCGGACCGAAAGAGACCCAGTACTTCGGGCCA	CSARLGPKETQYF	In	VDJ	1	58	7.149460708782742E-4	9.386632141123159E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	3	1	7	3	4	3	26	37	45	41	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARLGPKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGTAGGCAGGGGGGACGAGCAGTACTTCGGGCCG	CASSEVGRGDEQYF	In	VDJ	1	58	7.149460708782742E-4	9.386632141123159E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	1	5	4	1	23	39	50	43	51	TCRBV02,TCRBV09													CASSEVGRGDEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSLRENTEAFF	In	VDJ	1	59	7.272727272727272E-4	9.548470626314937E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	2	0	8	1	1	0	26	41	-1	42	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRENTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGTTACTAGCGGGACCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	59	7.272727272727272E-4		43	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	3	3	2	4	1	26	34	48	38	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCCCGGGGAGGCGGCTGGAACACTGAAGCTTTCTTTGGACAA	CSASRGGGWNTEAFF	In	VDJ	1	59	7.272727272727272E-4	9.548470626314937E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	1	1	6	6	26	34	46	40	52		TCRBV20-01,TCRBV20-or09_02												CSASRGGGWNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTACTAGCGGGGGGAGAGACCCAGTACTTCGGGCCA	CASSQVLAGGETQYF	In	VDJ	1	59	7.272727272727272E-4	9.548470626314937E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	3	1	4	1	0	23	39	-1	40	52	TCRBV01,TCRBV04													CASSQVLAGGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGACTTCTCGGGGAGCCAGTACTTCGGGCCA	CASSLDFSGSQYF	In	VDJ	1	59	7.272727272727272E-4	9.548470626314937E-4	39				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	8	3	10	6	2	18	34	45	40	47	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02				01,02								CASSLDFSGSQYF+X+TCRBJ02-05		TCRBD02-01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCGGGACAGGGATGTACAATACGCAGTATTTTGGCCCA	CASSPGTGMYNTQYF	In	VDJ	1	60	7.395993836671802E-4	9.710309111506716E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	7	3	7	18	30	42	33	49	TCRBV07,TCRBV11													CASSPGTGMYNTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCGACCCCTGGGATCGACGAGCAGTACGTCGGGCCG	CASSSTPGIDEQYV	In	VDJ	1	60	7.395993836671802E-4	9.710309111506716E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	4	0	8	17	8	15	18	31	43	39	58	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTPGIDEQYV+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGTAACTCCGACCGGGCGGTCTGAAGCTTTCTTTGGACAA	CSAVTPTGRSEAFF	In	VDJ	1	62	7.642526964560863E-4	0.0010033986081890273	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	8	0	6	13	3	26	34	51	47	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAVTPTGRSEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCGGCGGCGGTCGGGGCACTGAAGCTTTCTTTGGACAA	CSARAGGGRGTEAFF	In	VDJ	1	62	7.642526964560863E-4	0.0010033986081890273	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	8	3	4	11	0	26	39	-1	50	55		TCRBV20-01,TCRBV20-or09_02												CSARAGGGRGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCCCAGCGGGATCAAGAGACCCAGTACTTCGGGCCA	CASSSQRDQETQYF	In	VDJ	1	62	7.642526964560863E-4	0.0010033986081890273	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	6	3	2	3	1	18	31	41	34	42	TCRBV05,TCRBV11													CASSSQRDQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCCCGCGCCGGGACGGGAGAGACCCAGTACTTCGGGCCA	CASSSRAGTGETQYF	In	VDJ	1	63	7.765793528505393E-4	0.001019582456708205	45	TCRBV12						TCRBJ02	TCRBJ02-05	01	6	0	7	4	10	3	26	37	52	47	55		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRAGTGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACAGGGTGGGTCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	63	7.765793528505393E-4		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	3	4	0	5	26	-1	47	39	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTCATCGGGGGCCGGGCTTACAATGAGCAGTTCTTCGGGCCA	CSAFIGGRAYNEQFF	In	VDJ	1	63	7.765793528505393E-4	0.001019582456708205	45	TCRBV20						TCRBJ02	TCRBJ02-01	01	5	6	0	4	6	6	26	35	47	41	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAFIGGRAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCACACGACATCCCGCCGGACTAGCGGGAGGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	64	7.889060092449923E-4		49	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	10	1	0	5	14	0	26	30	-1	44	59		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCRTGTATSKCTGTGCTAGCAGCTGGGGGAGAGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSWGRGSYNEQFF	In	VDJ	1	64	7.889060092449923E-4	0.0010357663052273831	45	unresolved						TCRBJ02	TCRBJ02-01	01	4	6	1	0	0	5	18	-1	36	31	41	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWGRGSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAACTCACCAGGACCCAGAGCTCCTACGAGCAGTACGTCGGGCCG	CASSELTRTQSSYEQYV	In	VDJ	1	64	7.889060092449923E-4	0.0010357663052273831	51	unresolved						TCRBJ02	TCRBJ02-07	01	2	1	7	17	7	23	23	38	49	45	72	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSELTRTQSSYEQYV+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTTAGCGACTGAGCAGTTCTTCGGGCCA	CASSQDLATEQFF	In	VDJ	1	65	8.012326656394453E-4	0.001051950153746561	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	5	6	9	2	2	26	43	50	45	52		TCRBV03-01,TCRBV03-02				01,02								CASSQDLATEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTGGGCGAGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CATSDFGRGSYNEQFF	In	VDJ	1	67	8.258859784283513E-4	0.0010843178507849167	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	11	0	1	5	0	24	41	-1	46	51		TCRBV24-01,TCRBV24-or09_02												CATSDFGRGSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATATGTGGGGGCACAGGAGAATGAGCAGTTCTTCGGGCCA	CSARYVGAQENEQFF	In	VDJ	1	68	8.382126348228043E-4	0.0011005016993040945	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	6	0	7	5	7	26	38	49	43	56		TCRBV20-01,TCRBV20-or09_02												CSARYVGAQENEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACAGGGAAGTCAGCCCCAGCATTTTGGTGAT	CASSEQGSQPQHF	In	VDJ	1	70	8.628659476117103E-4	0.0011328693963424503	39	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	3	6	0	3	23	-1	43	38	46		TCRBV06-01,TCRBV06-08												CASSEQGSQPQHF+TCRBV06-X+TCRBJ01-05	TCRBV06	TCRBD01-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGACGGCGTCACAGATACGCAGTATTTTGGCCCA	CASSDGVTDTQYF	In	VDJ	1	71	8.751926040061633E-4	0.001149053244861628	39	unresolved						TCRBJ02	TCRBJ02-03	01	3	9	0	2	1	2	23	37	41	38	43	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDGVTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACCCAGGAACAGGGGAACTATGGCTACATCTTCGGTTCG	CSATQEQGNYGYIF	In	VDJ	1	72	8.875192604006164E-4	0.0011652370933808059	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	2	16	9	14	26	34	50	43	64		TCRBV20-01,TCRBV20-or09_02												CSATQEQGNYGYIF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGACTTTCCTTACAATGAGCAGTTCTTCGGGCCA	CSARRDFPYNEQFF	In	VDJ	1	73	8.998459167950694E-4	0.0011814209418999839	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	10	4	1	5	26	38	45	39	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARRDFPYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTTGGACGACAGCCAGTACTTCGGCGCC	CASSQDLDDSQYF	In	VDJ	1	73	8.998459167950694E-4	0.0011814209418999839	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	2	5	13	7	1	23	40	52	47	53	TCRBV01,TCRBV04													CASSQDLDDSQYF+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATTGGGCGGGAACACTGAAGCTTTCTTTGGACAA	CASSELGGNTEAFF	In	VDJ	1	74	9.121725731895224E-4	0.0011976047904191617	42	TCRBV06						TCRBJ01	TCRBJ01-01	01	2	8	0	1	2	2	23	38	44	40	46		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSELGGNTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGTGTGATGGCTTTTATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	75	9.244992295839754E-4		41				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	9	0	5	6	4	18	29	38	35	42	TCRBV05,TCRBV11,TCRBV12	TCRBV05-03,TCRBV11-03,TCRBV12-02												X+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGTAGTTGCCGTAGATACGCAGTATTTTGGCCCA	CASSLVVAVDTQYF	In	VDJ	1	75	9.244992295839754E-4	0.0012137886389383395	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	5	8	5	2	7	18	32	37	34	44	TCRBV05,TCRBV11					01,02								CASSLVVAVDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTCCCACGGGACAGGGGGATCAGTACTTCGGGCCG	CASSPTGQGDQYF	In	VDJ	1	75	9.244992295839754E-4	0.0012137886389383395	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	1	10	5	2	23	35	51	40	53	TCRBV02,TCRBV12													CASSPTGQGDQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGGAGGGTTCGGAAACATTCAGTACTTCGGCGCC	CASSGGFGNIQYF	In	VDJ	1	77	9.491525423728814E-4	0.0012461563359766952	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	11	0	6	0	5	23	-1	41	36	46	TCRBV09,TCRBV21													CASSGGFGNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGGGACAGAGCAATCAGCCCCAGCATTTTGGTGAT	CSAMGQSNQPQHF	In	VDJ	1	78	9.614791987673344E-4	0.001262340184495873	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	5	1	1	0	26	36	-1	37	44		TCRBV20-01,TCRBV20-or09_02												CSAMGQSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGCGCTCACAGATCATTCACCCCTCCACTTTGGGAAC	CASSLALTDHSPLHF	In	VDJ	1	78	9.614791987673344E-4	0.001262340184495873	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	3	5	8	7	3	18	32	43	39	46	TCRBV07,TCRBV11													CASSLALTDHSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTTTTTGTAGGGGCTGGAGAGACCCAGTACTTCGGGCCA	CASSFFVGAGETQYF	In	VDJ	1	80	9.861325115562403E-4	0.0012947078815342288	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	5	2	4	6	4	26	40	51	46	55		TCRBV12-03,TCRBV12-04												CASSFFVGAGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGCAGGGCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	80	9.861325115562403E-4		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	3	5	5	1	24	36	46	41	47		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGAAGAAACATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	82	0.0010107858243451463		43	TCRBV20						TCRBJ01	TCRBJ01-06	01	2	0	8	5	1	6	26	38	43	39	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCCTGGGACCAGGGATAATGAACACTGAAGCTTTCTTTGGACAA	CASSLGPGIMNTEAFF	In	VDJ	1	82	0.0010107858243451463	0.0013270755785725846	48	unresolved						TCRBJ01	TCRBJ01-01	01	6	0	7	0	3	9	23	34	42	37	51	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPGIMNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAGACTAGTTGCGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	83	0.0010231124807395995		47	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	8	0	2	5	22	34	42	36	47	TCRBV02,TCRBV12					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGCCTCAGGTTCCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	83	0.0010231124807395995		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	4	4	3	4	3	24	33	41	37	44		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CGTTTGGTGGTCAGGRRMYCRGCMSKGTATKTCTGTGCCAGCAGCTTAAGGCTCCCGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSLRLPSSGNTIYF	In	VDJ	1	83	0.0010231124807395995	0.0013432594270917624	48	unresolved						TCRBJ01	TCRBJ01-03	01	2	5	4	0	0	8	18	-1	36	33	44	TCRBV11,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRLPSSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCATTGGTACTTCACCCCTTTACTTTGGGAAC	CASSIGTSPLYF	In	VDJ	1	83	0.0010231124807395995	0.0013432594270917624	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	4	3	10	20	6	10	23	35	44	41	54	TCRBV09,TCRBV21					01,02								CASSIGTSPLYF+X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACAAAGGGACTAGACCAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	84	0.0010354391371340524		50	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	8	5	4	4	23	40	52	44	56	TCRBV01,TCRBV04					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCGCTAACAGGGGGAGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	86	0.0010600924499229584		47	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	1	3	6	4	26	38	52	44	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCRTGTATSKCTGTGCCAGCGCACCCGGTGGGACTCGGAACACTGAAGCTTTCTTTGGACAA	CASAPGGTRNTEAFF	In	VDJ	1	86	0.0010600924499229584	0.001391810972649296	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	8	0	10	1	9	2	18	27	42	36	44	TCRBV07,TCRBV11					01,02								CASAPGGTRNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTGGAACAAAACACTGAAGCTTTCTTTGGACAA	CASSLEQNTEAFF	In	VDJ	1	87	0.0010724191063174115	0.0014079948211684738	39	unresolved						TCRBJ01	TCRBJ01-01	01	4	1	8	2	1	4	23	36	40	37	44	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEQNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAAGATCGGCGCCGACAGCTTTTCCACCTTCGGTTCG	CSAKIGADSFSTF	In	VDJ	1	87	0.0010724191063174115	0.0014079948211684738	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	5	13	13	6	26	34	52	47	58		TCRBV20-01,TCRBV20-or09_02												CSAKIGADSFSTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCAACTAGCGGGGGGGGGCCAGATACGCAGTATTTTGGCCCA	CASSSTSGGGPDTQYF	In	VDJ	1	88	0.0010847457627118644	0.0014241786696876518	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	3	0	4	3	3	26	38	54	41	57		TCRBV03-01,TCRBV03-02												CASSSTSGGGPDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGGACGACATTCATGAACACTGAAGCTTTCTTTGGACAA	CSASRTTFMNTEAFF	In	VDJ	1	88	0.0010847457627118644	0.0014241786696876518	45	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	1	7	0	2	8	26	37	43	39	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRTTFMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCCGGGGACTAGCGGGGTTTAAGACCCAGTACTTCGGGCCA	CASSPRGLAGFKTQYF	In	VDJ	1	90	0.0011093990755007704	0.0014565463667260074	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	6	5	4	26	38	56	43	60		TCRBV12-03,TCRBV12-04												CASSPRGLAGFKTQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCATCCCCAGACGACCAGAGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	90	0.0011093990755007704		53	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	2	7	0	10	8	26	37	50	47	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTTGGCCGGTGGCGGGCCCAATGAGCAGTTCTTCGGGCCA	CASSLAGGGPNEQFF	In	VDJ	1	90	0.0011093990755007704	0.0014565463667260074	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	7	4	6	8	2	19	33	46	41	48	TCRBV07,TCRBV11					01,02								CASSLAGGGPNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGTGGCATCTTATAATTCACCCCTCCACTTTGGGAAC	CASSLVASYNSPLHF	In	VDJ	1	90	0.0011093990755007704	0.0014565463667260074	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	9	0	4	1	4	18	34	38	35	42	TCRBV07,TCRBV11													CASSLVASYNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCGAAACAGGGGGCTCGGCCGGGGAGCTGTTTTTTGGAGAA	CASSETGGSAGELFF	In	VDJ	1	91	0.0011217257318952233	0.0014727302152451854	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	0	6	3	4	18	30	42	33	46	TCRBV07,TCRBV11													CASSETGGSAGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCAGCGGGAGGTGAGCATTCAGTACTTCGGCGCC	CASSQDQREVSIQYF	In	VDJ	1	92	0.0011340523882896764	0.0014889140637643632	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	6	1	9	2	4	26	43	54	45	58		TCRBV03-01,TCRBV03-02												CASSQDQREVSIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01*02	TCRBJ02-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGTCGGGAACGTACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	92	0.0011340523882896764		41	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	8	3	5	1	4	19	35	41	36	45	TCRBV07,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGGCCGGGACAGGGGAGGATGAAAAACTGTTTTTTGGCAGT	CASSLAGTGEDEKLFF	In	VDJ	1	95	0.0011710323574730353	0.0015374656093218968	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	2	6	4	3	19	33	47	37	50	TCRBV07,TCRBV11													CASSLAGTGEDEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCATCGCCGGACAGGRAAACACTGAAGCTTTCTTTGGACAA	CASIAGQXNTEAFF	In	VDJ	1	96	0.0011833590138674885	0.0015536494578410746	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	1	4	2	5	2	22	32	44	37	46	TCRBV02,TCRBV12													CASIAGQXNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCATCAGCGGGGGCGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSISGGGTGELFF	In	VDJ	1	96	0.0011833590138674885	0.0015536494578410746	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	6	2	5	3	4	18	30	41	33	45	TCRBV05,TCRBV07													CASSISGGGTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTACCTTAGGTGGAAACACCATATATTTTGGAGAG	CASSPTLGGNTIYF	In	VDJ	1	98	0.0012080123266563945	0.0015860171548794304	42	TCRBV03						TCRBJ01	TCRBJ01-03	01	4	5	4	3	7	0	26	39	-1	46	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTLGGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGGGGATCCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	99	0.0012203389830508474		41	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	8	1	1	0	4	26	-1	44	37	48		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCTCTAGCGGGAGCAGAGGGGAGCTGTTTTTTGGAGAA	CSAPSSGSRGELFF	In	VDJ	1	102	0.0012573189522342065	0.0016507525489561417	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	4	2	8	4	4	26	35	49	39	53		TCRBV20-01,TCRBV20-or09_02												CSAPSSGSRGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAGGGACAGGGGATACCTACGAGCAGTACGTCGGGCCG	CASSLGTGDTYEQYV	In	VDJ	1	102	0.0012573189522342065	0.0016507525489561417	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	2	17	0	18	22	-1	47	38	65		TCRBV12-03,TCRBV12-04												CASSLGTGDTYEQYV+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGCCACCAGGGTTGGGTTGGACACTGAAGCTTTCTTTGGACAA	CASSQATRVGLDTEAFF	In	VDJ	1	103	0.0012696456086286594	0.0016669363974753195	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	3	4	9	23	39	48	43	57	TCRBV01,TCRBV04													CASSQATRVGLDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGCAGGGGGAATACAATGAGCAGTTCTTCGGGCCA	CASSVGQGEYNEQFF	In	VDJ	1	103	0.0012696456086286594	0.0016669363974753195	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	1	4	6	2	24	36	49	42	51	TCRBV09,TCRBV21													CASSVGQGEYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCCGACTAGCGGGAGGCCAAGATACGCAGTATTTTGGCCCA	CASSRLAGGQDTQYF	In	VDJ	1	106	0.0013066255778120186	0.0017154879430328531	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	2	1	5	1	3	22	34	48	35	51	TCRBV07,TCRBV11													CASSRLAGGQDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACAGGGGGCTAGAGACCCAGTACTTCGGGCCA	CSANRGLETQYF	In	VDJ	1	107	0.0013189522342064715	0.0017316717915520311	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	0	4	0	1	26	-1	45	36	46		TCRBV20-01,TCRBV20-or09_02												CSANRGLETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGCTAGCGGGAGGACCGGGGAGCTGTTTTTTGGAGAA	CASSASGRTGELFF	In	VDJ	1	109	0.0013436055469953775	0.0017640394885903867	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	4	1	5	0	0	24	-1	-1	37	48		TCRBV24-01,TCRBV24-or09_02												CASSASGRTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGTTAACAGGTTTAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	111	0.0013682588597842835		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	3	4	2	4	4	24	33	42	37	46		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGGACGGACAAGAGACCCAGTACTTCGGGCCA	CASSQADGQETQYF	In	VDJ	1	112	0.0013805855161787366	0.0018125910341479203	42	TCRBV03						TCRBJ02	TCRBJ02-05	01	1	1	7	2	1	3	26	42	47	43	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQADGQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGCCTAGCAACACCGGGGAGCTGTTTTTTGGAGAA	CSAMPSNTGELFF	In	VDJ	1	112	0.0013805855161787366	0.0018125910341479203	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	4	7	2	3	0	26	36	-1	39	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSAMPSNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTACAGGGGGCTTGATGGATGAGCAGTTCTTCGGGCCA	CSARGTGGLMDEQFF	In	VDJ	1	113	0.0013929121725731895	0.0018287748826670983	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	3	0	8	2	7	26	39	50	41	57		TCRBV20-01,TCRBV20-or09_02												CSARGTGGLMDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACAGCCATGAACACTGAAGCTTTCTTTGGACAA	CSARGTAMNTEAFF	In	VDJ	1	115	0.0014175654853620955	0.0018611425797054539	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	5	0	0	3	26	-1	45	39	48		TCRBV20-01,TCRBV20-or09_02												CSARGTAMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTACGAAGGAGGGTCGGGCAATCAGCCCCAGCATTTTGGTGAT	CSAYEGGSGNQPQHF	In	VDJ	1	117	0.0014422187981510016	0.0018935102767438097	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	10	0	2	7	4	26	34	47	41	51		TCRBV20-01,TCRBV20-or09_02												CSAYEGGSGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGAGGGACTAGCATCTACGAGCAGTACTTCGGGCCG	CASRGTSIYEQYF	In	VDJ	1	118	0.0014545454545454545	0.0019096941252629875	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	7	3	1	2	23	34	44	35	46	TCRBV06,TCRBV10					01,02								CASRGTSIYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGTTCGGGGACAGGGAAGAACACTGAAGCTTTCTTTGGACAA	CASSGTGKNTEAFF	In	VDJ	1	120	0.0014791987673343605	0.0019420618223013433	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	0	3	1	4	2	23	31	44	35	46	TCRBV01,TCRBV04													CASSGTGKNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCTAGCGGGACCCAAGAGACCCAGTACTTCGGGCCA	CASSSSGTQETQYF	In	VDJ	1	120	0.0014791987673343605	0.0019420618223013433	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	4	3	1	0	1	18	-1	40	31	41	TCRBV07,TCRBV11													CASSSSGTQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCCGGAACTATGGCTACACCTTCGGTTCG	CASSQVRNYGYTF	In	VDJ	1	122	0.0015038520801232665	0.001974429519339699	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	8	5	2	2	0	26	42	-1	44	47		TCRBV03-01,TCRBV03-02				01,02								CASSQVRNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCAAGTGGGACAAGATACGAGCAGTACTTCGGGCCG	CASSSSGTRYEQYF	In	VDJ	1	123	0.0015161787365177196	0.0019906133678588766	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	6	4	5	3	18	31	42	36	45	TCRBV07,TCRBV11													CASSSSGTRYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAGAGGATAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARGEDSSYNEQFF	In	VDJ	1	124	0.0015285053929121725	0.0020067972163780546	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	11	1	0	2	4	26	39	45	41	49		TCRBV20-01,TCRBV20-or09_02												CSARGEDSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTAGGGACAGGCACAGATACGCAGTATTTTGGCCCA	CATSVGTGTDTQYF	In	VDJ	1	125	0.0015408320493066256	0.0020229810648972326	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	5	1	2	0	24	37	-1	39	46		TCRBV24-01,TCRBV24-or09_02												CATSVGTGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAATAAGGGGGGGAGTTTTAGCACAGATACGCAGTATTTTGGCCCA	CASNKGGSFSTDTQYF	In	VDJ	1	125	0.0015408320493066256	0.0020229810648972326	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	11	9	0	0	7	6	24	31	45	38	51		TCRBV24-01,TCRBV24-or09_02												CASNKGGSFSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAATTTGAGGGCGGGAGGATTGACAGATACGCAGTATTTTGGCCCA	CSARNLRAGGLTDTQYF	In	VDJ	1	126	0.0015531587057010785	0.00203916491341641	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	7	1	3	9	4	26	38	55	47	59		TCRBV20-01,TCRBV20-or09_02												CSARNLRAGGLTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGGGTCAGGGGGGCTCTACGAGCAGTACTTCGGGCCG	XASSQGSGGLYEQYF	In	VDJ	1	127	0.0015654853620955317	0.0020553487619355882	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	1	3	3	3	23	39	49	42	52	TCRBV01,TCRBV04													XASSQGSGGLYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCTACCTCTCTGGAAACACCATATATTTTGGAGAG	CSARDLYLSGNTIYF	In	VDJ	1	131	0.0016147919876733437	0.0021200841560123	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	0	4	9	0	3	3	26	40	46	43	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLYLSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01	TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAGGGGCGGTGCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	131	0.0016147919876733437		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	2	0	0	7	26	-1	41	35	48		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAACGACTAGCGGAAGGATACAGTACTTCGGGCCG	CASSQGTTSGRIQYF	In	VDJ	1	132	0.0016271186440677966	0.0021362680045314774	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	2	5	10	4	7	26	42	55	46	62		TCRBV03-01,TCRBV03-02				01,02								CASSQGTTSGRIQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCAGACAGGGGAGAGACCCAGTACTTCGGGCCA	CASSPDRGETQYF	In	VDJ	1	133	0.0016394453004622497	0.0021524518530506554	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	2	4	4	0	26	37	-1	41	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPDRGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGCGGGGTCGATGAGCAGTTCTTCGGGCCA	CSAREGGVDEQFF	In	VDJ	1	133	0.0016394453004622497	0.0021524518530506554	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	7	3	8	2	3	26	40	48	42	51		TCRBV20-01,TCRBV20-or09_02												CSAREGGVDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAATGGGACTATGCCAGTACGGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	138	0.0017010785824345146		52	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	9	9	4	11	26	43	54	47	65		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAATCTACACCCGAACACTGAAGCTTTCTTTGGACAA	CSANLHPNTEAFF	In	VDJ	1	139	0.0017134052388289675	0.0022495549441657226	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	3	6	1	6	3	26	34	43	40	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSANLHPNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTAACAGGGGAGCAGCCCCAGCATTTTGGTGAT	CSARVTGEQPQHF	In	VDJ	1	139	0.0017134052388289675	0.0022495549441657226	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	3	2	7	2	2	26	39	48	41	50		TCRBV20-01,TCRBV20-or09_02												CSARVTGEQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGGGGCACTACAATGAGCAGTTCTTCGGGCCA	CSASGGHYNEQFF	In	VDJ	1	139	0.0017134052388289675	0.0022495549441657226	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	1	3	0	2	26	-1	44	37	46		TCRBV20-01,TCRBV20-or09_02												CSASGGHYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTGGCGGGAGCGGGAGCAGTTCTTCGGGCCA	CSASWREREQFF	In	VDJ	1	140	0.0017257318952234207	0.0022657387926849006	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	2	10	3	3	26	37	47	40	50		TCRBV20-01,TCRBV20-or09_02												CSASWREREQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAAAGGACAGGGGAGCTATGGCTACACCTTCGGTTCG	CASKGQGSYGYTF	In	VDJ	1	140	0.0017257318952234207	0.0022657387926849006	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	2	4	2	2	22	32	43	34	45	TCRBV02,TCRBV12													CASKGQGSYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAACGGAAATCCTTTCAATTCGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	141	0.0017380585516178736		49	TCRBV03						TCRBJ01	TCRBJ01-01	01	5	1	8	4	3	15	26	38	44	41	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAAGTGGACAAAAGCACTGAAGCTTTCTTTGGACAA	CAISEVDKSTEAFF	In	VDJ	1	141	0.0017380585516178736	0.002281922641204078	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	6	4	1	4	23	39	45	40	49	TCRBV06,TCRBV10													CAISEVDKSTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAGGGTTACGGCAAAAACATTCAGTACTTCGGCGCC	CASSEGYGKNIQYF	In	VDJ	1	144	0.0017750385208012327	0.0023304741867616117	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	11	0	3	0	6	22	-1	39	34	45	TCRBV09,TCRBV12													CASSEGYGKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCATCGACGACAGGGATGAGCAGTTCTTCGGGCCA	CASIDDRDEQFF	In	VDJ	1	145	0.0017873651771956856	0.0023466580352807897	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	11	2	3	8	8	0	24	31	-1	39	46		TCRBV24-01,TCRBV24-or09_02												CASIDDRDEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGCGGTCGGGACTCCTGGACTCTACGAGCAGTACTTCGGGCCG	CASSLAVGTPGLYEQYF	In	VDJ	1	145	0.0017873651771956856	0.0023466580352807897	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	10	3	4	8	18	35	45	39	53	TCRBV07,TCRBV11					01,02								CASSLAVGTPGLYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCTCGATCAACGAAGGTACGCAGTATTTTGGCCCA	CASSINEGTQYF	In	VDJ	1	149	0.0018366718027734976	0.0024113934293575013	36	TCRBV03						TCRBJ02	TCRBJ02-03	01	8	5	4	8	11	0	26	35	-1	46	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSINEGTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGAAAGGGAGCTCTGGAAACACCATATATTTTGGAGAG	CSAPKGSSGNTIYF	In	VDJ	1	155	0.0019106317411402157	0.0025084965204725685	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	9	2	0	7	0	26	34	-1	41	46		TCRBV20-01,TCRBV20-or09_02												CSAPKGSSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01*02	TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACCCGGGGGCGCCCATCTACAATGAGCAGTTCTTCGGGCCA	CSANPGAPIYNEQFF	In	VDJ	1	157	0.0019352850539291217	0.002540864217510924	45	TCRBV20						TCRBJ02	TCRBJ02-01	01	4	6	0	3	4	6	26	36	46	40	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSANPGAPIYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGACTAGCGGGATAGATGAGCAGTTCTTCGGGCCA	CASSLATSGIDEQFF	In	VDJ	1	158	0.0019476117103235748	0.002557048066030102	45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	2	3	8	0	3	18	-1	46	35	49	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLATSGIDEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCTGGGACTTAGCCCGGCGGAGACCCAGTACTTCGGGCCA	CASSLGLSPAETQYF	In	VDJ	1	158	0.0019476117103235748	0.002557048066030102	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	10	5	2	10	19	31	39	33	49	TCRBV07,TCRBV11					01,02								CASSLGLSPAETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAATCCCGGAATCTATGGCTACACCTTCGGTTCG	CATNPGIYGYTF	In	VDJ	1	163	0.0020092449922958396	0.0026379673086259913	36	TCRBV24						TCRBJ01	TCRBJ01-02	01	8	1	8	4	5	2	24	34	42	39	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATNPGIYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCCCGGCTAGCGGGGGATCCACAGATACGCAGTATTTTGGCCCA	CASSPASGGSTDTQYF	In	VDJ	1	163	0.0020092449922958396	0.0026379673086259913	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	2	2	4	3	18	30	44	34	47	TCRBV03,TCRBV11													CASSPASGGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGTCAGCGGGATGGGGACCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	167	0.0020585516178736516		53				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	6	3	2	3	6	18	35	45	38	51	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												X+X+TCRBJ02-04		TCRBD02-01*02	TCRBJ02-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGTCATGAAAAACTGTTTTTTGGCAGT	CASSQGHEKLFF	In	VJ	1	169	0.002083204930662558	0.0027350703997410584	36	unresolved						TCRBJ01	TCRBJ01-04	01	1	0	0	6	0	3	23	-1	39	-1	42	TCRBV01,TCRBV04													CASSQGHEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TCAGGAGACWCRGCMSKGTATKTCTGTGCCAGCAGCCCCGGAGGGCTAGCGGGGCTCACAGATACGCAGTATTTTGGCCCA	CASSPGGLAGLTDTQYF	In	VDJ	1	170	0.002095531587057011	0.0027512542482602364	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	2	9	2	24	36	54	45	56	TCRBV11,TCRBV21													CASSPGGLAGLTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGGGGACTCRGCYSTSTATCTCTGTGCCAGCAGCCCTGGACTAGCGGGCCGTGCGGATGAGCAGTTCTTCGGGCCA	CASSPGLAGRADEQFF	In	VDJ	1	175	0.0021571648690292757	0.0028321734908561256	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	4	8	3	8	22	34	48	37	56	TCRBV05,TCRBV07					01,02								CASSPGLAGRADEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAGTTGTCCATTTACACGCACGAAACACCATATATTTTGGAGAG		Out	VDJ	1	176	0.002169491525423729		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	3	6	5	12	5	26	41	56	53	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCSRGGGACTYRGCTGTGTATYTYTGTGCCAGCAGCTAGGACTGGGCAGCGATAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	177	0.002181818181818182		47	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	1	10	4	1	9	22	35	41	36	50	TCRBV07,TCRBV12					01,02								X+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTCGACTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CATSDSTSGSTDTQYF	In	VDJ	1	178	0.002194144838212635	0.002880725036413659	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	2	4	0	3	0	24	38	-1	41	51		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDSTSGSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGCCATCCTACGAGCAGTACTTTGGGCCG	CSASGPSYEQYF	In	VDJ	1	180	0.002218798151001541	0.0029130927334520148	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	8	0	19	1	20	26	37	42	38	62		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGPSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGGCATGAACGGGAGATTGGATCAGGTCAATGAGCAGTTCTTCGGGCCA	CASSLGMNGRLDQVNEQFF	In	VDJ	1	181	0.002231124807395994	0.0029292765819711928	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	8	2	6	9	12	18	32	47	41	59	TCRBV05,TCRBV11													CASSLGMNGRLDQVNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTCGGGGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	186	0.0022927580893682587		40	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	2	1	0	0	22	-1	-1	36	42		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTACACCTCCTTAACCAGGGGAACGGGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	192	0.002366718027734977		52	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	2	7	15	6	26	35	56	50	62		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGCCGCAGGGGGGGATGAGACCCCAGCATTTTGGTGAT	CASRPQGGMRPQHF	In	VDJ	1	192	0.002366718027734977	0.003107298915682149	42	TCRBV24						TCRBJ01	TCRBJ01-05	01	7	4	1	10	4	8	24	35	46	39	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPQGGMRPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCRTGTATSKCTGTGCTAGCGGATCCCGGGACGTCCACGGGGAAGAGACCCAGTACTTCGGGCCA	CASGSRDVHGEETQYF	In	VDJ	1	193	0.00237904468412943	0.003123482764201327	48	unresolved			unresolved			TCRBJ02	TCRBJ02-05	01	12	5	5	3	0	20	18	-1	29	23	49	TCRBV07,TCRBV12			TCRBD01,TCRBD02										CASGSRDVHGEETQYF+X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATGGGGTTAGCGGGCAAGAGACCCAGTACTTCGGGCCA	CASSQDGVSGQETQYF	In	VDJ	1	194	0.0023913713405238827	0.003139666612720505	48				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	5	4	2	6	0	18	35	-1	41	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQDGVSGQETQYF+X+TCRBJ02-05		TCRBD02-01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGGGCCTAATTGGGAGCAGTTCTTCGGGCCA	CASSGPNWEQFF	In	VDJ	1	201	0.002477657935285054	0.00325295355235475	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	8	0	10	0	8	26	-1	42	38	50		TCRBV12-03,TCRBV12-04												CASSGPNWEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCAGTACAATGGACAGTGGGGTTGTTCAGTACTTCGGCGCC	CASSSTMDSGVVQYF	In	VDJ	2	210	0.002588597842835131	0.0033986081890273506	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	1	5	11	9	8	26	37	52	46	60		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSSTMDSGVVQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD01-01*01	TCRBJ02-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTAACTAGCACAGATACGCAGTATTTTGGCCCA	CSARVTSTDTQYF	In	VDJ	2	211	0.002600924499229584	0.0034147920375465286	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	3	10	0	2	0	26	39	-1	41	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVTSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCAGTCGGCAGGGGATTCACCCCTCCACTTTGGGAAC	CSASQSAGDSPLHF	In	VDJ	2	211	0.002600924499229584	0.0034147920375465286	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	4	2	8	8	0	26	37	-1	45	51		TCRBV20-01,TCRBV20-or09_02												CSASQSAGDSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGTCATGTTCCATTTCATACATCATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	213	0.00262557781201849		55	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	3	6	5	17	2	26	39	59	56	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACGGCATGACTAGCGGGGGAGCAGATACGCAGTATTTTGGCCCA	CASSHGMTSGGADTQYF	In	VDJ	2	224	0.0027611710323574732	0.0036251820682958406	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	2	2	4	6	2	26	40	58	46	60		TCRBV03-01,TCRBV03-02												CASSHGMTSGGADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGATCGCTATTCGGATTTTGAATAACATTCAATACTTCGGCGCC		Out	VDJ	2	233	0.00287211093990755		43	TCRBV20						TCRBJ02	TCRBJ02-04	01	7	1	8	16	10	17	26	33	46	43	63		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-04	TCRBV20		TCRBJ02-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCGGGGTGAAAAACTGTTTTTTGGCAGT	CSAPRGEKLFF	In	VDJ	2	243	0.0029953775038520803	0.00393267519016022	33	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	3	7	3	0	26	35	-1	38	43		TCRBV20-01,TCRBV20-or09_02												CSAPRGEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*01	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGACGACCCTACTAGCGGGATTCTAGGGGAGACCCAGTACTTCGGGCCA	CASSDDPTSGILGETQYF	In	VDJ	2	270	0.0033281972265023115	0.004369639100178022	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	3	3	5	8	8	23	36	54	44	62	TCRBV09,TCRBV21													CASSDDPTSGILGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGACAGGGCCTCAATCAGCCCCAGCATTTTGGTGAT	CASSQGQGLNQPQHF	In	VDJ	2	275	0.003389830508474576	0.004450558342773912	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	2	3	3	0	3	23	-1	46	39	49	TCRBV01,TCRBV04													CASSQGQGLNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCGCGGGGACCCTACAGAACAATGAGCAGTTCTTCGGGCCA	CSAPAGTLQNNEQFF	In	VDJ	2	286	0.003525423728813559	0.004628580676484868	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	3	5	3	10	26	35	44	38	54		TCRBV20-01,TCRBV20-or09_02												CSAPAGTLQNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGACTAGCGGGCGTCTACAATGAGCAGTTCTTCGGGCCA	CASSPRLAGVYNEQFF	In	VDJ	2	293	0.0036117103235747306	0.0047418676161191135	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	4	3	3	3	26	39	52	42	55		TCRBV03-01,TCRBV03-02				01,02								CASSPRLAGVYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGTTTTGGTCAGGCCGTGTTTTTTGGCAGT	CASSQGFGQAVFF	In	VDJ	2	311	0.0038335901386748845	0.005033176889464315	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	4	4	15	8	3	23	39	51	47	54	TCRBV01,TCRBV04													CASSQGFGQAVFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACAGGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLQGGSYNEQFF	In	VDJ	2	314	0.0038705701078582434	0.005081728435021848	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	1	0	2	1	24	36	46	38	47		TCRBV24-01,TCRBV24-or09_02												CASSLQGGSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTGACAGGGGTAGGCAAAAACATTCAGTACTTCGGCGCC	CSALTGVGKNIQYF	In	VDJ	2	319	0.003932203389830509	0.005162647677617737	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	2	2	3	3	4	26	34	45	37	49		TCRBV20-01,TCRBV20-or09_02												CSALTGVGKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
TTTCTGTGCCAGCAGCCAAGAGGCCCATAAAGCGGGGGGGCGCTTCGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	332	0.004092449922958398		64	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	6	0	1	9	8	4	21	40	30	48		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCCGTTTCCTGCCAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	341	0.004203389830508475		44	TCRBV03						TCRBJ02	TCRBJ02-05	01	5	4	6	3	13	0	26	38	-1	51	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTGGGACTAACCGGGGAGCTGTTTTTTGGAGAA	CASSLGLTGELFF	In	VDJ	3	381	0.004696456086286595	0.006166046285806765	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	9	5	2	0	26	38	-1	40	47		TCRBV12-03,TCRBV12-04				01,02								CASSLGLTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGACGATCCCTCCATTCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	444	0.005473035439137134		50	TCRBV03						TCRBJ02	TCRBJ02-01	01	4	0	7	5	0	15	26	-1	44	39	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATGGGAGGGTTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	4	568	0.007001540832049307		37	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	9	0	7	1	1	26	38	46	39	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*02	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACGGAAGCCGGGGAGCTGTTTTTTGGAGAA	CSARDTEAGELFF	In	VDJ	5	756	0.009318952234206472	0.012234989480498462	39	TCRBV20						TCRBJ02	TCRBJ02-02	01	0	1	8	6	3	2	26	40	46	43	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDTEAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGTTGGAAGGGGGCGAGAACACTGAAGCTTTCTTTGGACAA	CASSQELEGGENTEAFF	In	VDJ	5	761	0.009380585516178737	0.012315908723094352	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	0	1	6	2	26	43	56	49	58		TCRBV03-01,TCRBV03-02												CASSQELEGGENTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCTCACTCCTAGAGGGAGTCACCGGGGAGCTGTTTTTTGGAGAA	CASTSLLEGVTGELFF	In	VDJ	8	1079	0.013300462249614791	0.01746237255219291	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	9	2	4	13	1	26	36	54	49	55		TCRBV03-01,TCRBV03-02												CASTSLLEGVTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAAGGGCAGGTTCTGGAGGTAAACTGTTTTTTGGCAGT	CASSPRAGSGGKLFF	In	VDJ	8	1088	0.013411402157164869	0.017608027188865512	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	4	10	1	11	14	1	26	39	58	53	59		TCRBV03-01,TCRBV03-02												CASSPRAGSGGKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*02	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTCCGGGACAGGGGGTTACGAGCAGTACTTCGGGCCG		Out	VDJ	8	1145	0.014114021571648691		47				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	1	4	3	1	18	35	49	38	50	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAAATCCGGGACTAGCGGGCCGCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	16	2165	0.026687211093990755		53	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	0	4	17	6	18	26	41	59	47	77		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCTGTCCTCTAACTAGCGGGGGTTTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	154	0.0018983050847457628		56	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	3	2	1	9	2	23	36	56	45	58													Vb 7.1	X+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCCAGGGGGGCCGGGGAGCTGTTTTTTGGAGAA	CATSRARGAGELFF	In	VDJ	1	46	5.670261941448382E-4	7.444570318821816E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	4	1	6	1	1	18	34	42	35	43														CATSRARGAGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGGGGGGGCGCAGAGATTCGATGGCTACACCTTCGGTTCG	CATSRDGGAQRFDGYTF	In	VDJ	1	78	9.614791987673344E-4	0.001262340184495873	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	9	0	6	1	12	18	35	43	36	55														CATSRDGGAQRFDGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD02-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTATCGACTAGCGGGGATGAGCAGTTCTTCGGGCCA	CATSRVSTSGDEQFF	In	VDJ	1	86	0.0010600924499229584	0.001391810972649296	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	2	3	8	4	0	18	34	-1	38	49														CATSRVSTSGDEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTGGGACACCTTTTTTAATGAAAAACTGTTTTTTGGCAGT	CATSRDWDTFFNEKLFF	In	VDJ	1	88	0.0010847457627118644	0.0014241786696876518	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	0	6	4	2	7	18	35	43	37	50														CATSRDWDTFFNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTCCCAAGGGTTCAGCCCCAGCATTTTGGTGAT	CATSRVPRVQPQHF	In	VDJ	1	164	0.0020215716486902927	0.0026541511571451693	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-05	01	1	5	3	6	5	1	18	34	43	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRVPRVQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01		TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACGCAGCCATGTACCTGTGTGCCACCCGATGGGGGGACAAGAACACTGAAGCTTTCTTTGGACAA	CATRWGDKNTEAFF	In	VDJ	2	240	0.002958397534668721	0.0038841236446026865	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-01	01	8	0	6	1	7	1	18	27	40	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATRWGDKNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCTACGGGGTGAACGGGTGGTCGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	285	0.0035130970724191065		52	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	3	2	2	13	18	30	37	32	50														X+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCCCCCCGGGTTTGGGACTAATGAAAAACTGTTTTTTGGCAGT	CATSPPGFGTNEKLFF	In	VDJ	3	379	0.004671802773497689	0.006133678588768409	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	8	4	2	5	6	18	30	39	35	45						01,02								CATSPPGFGTNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD02-01	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGGGACTAGAGCCTACAATGAGCAGTTCTTCGGGCCA	CATSRDGTRAYNEQFF	In	VDJ	6	835	0.010292758089368258	0.013513513513513514	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	8	2	1	2	18	35	44	36	46						01,02								CATSRDGTRAYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATCTCTGTGCCAGCACCCGAGACAGGCAAGAGACCCAGTACTTTGGGCCA	CASTRDRQETQYF	In	VDJ	1	55	6.779661016949153E-4	8.901116685547824E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02			7	2	4	22	5	18	18	28	39	33	57								TCRBJ02-01,TCRBJ02-05						CASTRDRQETQYF+TCRBV07-02+TCRBJ02-X	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTCCCCAAGGGGACTGAAGCTTTCTTTGGACAA	CASSFPKGTEAFF	In	VDJ	1	55	6.779661016949153E-4	8.901116685547824E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	5	2	5	5	0	18	32	-1	37	42														CASSFPKGTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATCTCTGTGCCAGCCAGAATAGTATACTCAATGAGCAGTTCTTCGGGCCA	CASQNSILNEQFF	In	VDJ	1	60	7.395993836671802E-4	9.710309111506716E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-01	01	8	4	5	6	0	11	18	-1	30	27	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASQNSILNEQFF+TCRBV07-02+TCRBJ02-01	TCRBV07-02*01		TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCGCCTCGACAGGGTCCGAGCAGTACTTCGGGCCG	CASSASTGSEQYF	In	VDJ	1	64	7.889060092449923E-4	0.0010357663052273831	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	6	5	2	18	30	42	35	44														CASSASTGSEQYF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGACACACGGGGGGCAGGGTGGCTACACCTTCGGTTCG	CASSLTHGGQGGYTF	In	VDJ	1	40	4.930662557781202E-4	6.473539407671144E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	1	7	8	5	18	30	45	38	50														CASSLTHGGQGGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTGGGTAGCGGGGGATCCATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	41	5.053929121725732E-4		46	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	5	2	8	5	4	18	32	46	37	50														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGACTAGCGGGACGTTCGAGACCCAGTACTTCGGGCCA	CASSLTSGTFETQYF	In	VDJ	1	43	5.300462249614792E-4	6.95905486324648E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	2	3	5	2	5	18	30	43	32	48														CASSLTSGTFETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTGGGACAGGGGGTTCTACGAGCAGTACGTCGGGCCG	CASSFWDRGFYEQYV	In	VDJ	1	43	5.300462249614792E-4	6.95905486324648E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	1	17	2	16	18	32	45	34	61														CASSFWDRGFYEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTGGACTAGCGGGATTCGGAGAGACCCAGTACTTCGGGCCA	CASSSGLAGFGETQYF	In	VDJ	1	44	5.423728813559322E-4	7.120893348438259E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	1	3	4	2	5	18	31	45	33	50														CASSSGLAGFGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATACAGGGTCTGAACAATCAGCCCCAGCATTTTGGTGAT	CASSIQGLNNQPQHF	In	VDJ	1	45	5.546995377503852E-4	7.282731833630037E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	3	2	6	18	30	38	32	44														CASSIQGLNNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCATACGTACAGGGGGCGCTACCGGGGAGCTGTTTTTTGGAGAA	CASIRTGGATGELFF	In	VDJ	1	47	5.793528505392912E-4	7.606408804013595E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	3	0	5	5	3	18	28	42	33	45														CASIRTGGATGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCGACGACAGGTCAGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	49	6.040061633281972E-4		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	2	4	2	5	4	18	34	45	39	49														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTATCAGAGAGGGTTACTCTGAAGCTTTCTTTGGACAA	CASSIREGYSEAFF	In	VDJ	1	51	6.286594761171033E-4	8.253762744780709E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	11	0	6	7	5	18	29	41	36	46														CASSIREGYSEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGAAGGGACTCTGGAAACACCATATATTTTGGAGAG	CASSGRDSGNTIYF	In	VDJ	1	52	6.409861325115563E-4	8.415601229972488E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	5	0	8	0	4	0	18	30	-1	34	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGRDSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGACGGGACTAGATACAATGAGCAGTTCTTCGGGCCA	CASSDGTRYNEQFF	In	VDJ	1	56	6.902927580893683E-4	9.062955170739601E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	8	4	3	1	18	30	41	33	42						01,02								CASSDGTRYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTGGGGCTGTAGGTACGCAGTATTTTGGCCCA	CASSLGGAVGTQYF	In	VDJ	1	59	7.272727272727272E-4	9.548470626314937E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	7	0	8	2	6	18	34	41	36	47														CASSLGGAVGTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGATGGACTAGCGGAGAAGAGACCCAGTACTTCGGGCCA	CASSRWTSGEETQYF	In	VDJ	1	63	7.765793528505393E-4	0.001019582456708205	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	5	3	4	2	18	30	44	34	46						01,02								CASSRWTSGEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTATAAGGGCGGCATCAGCCCCAGCATTTTGGTGAT	CASSLV*GRHQPQHF	Stop	VDJ	1	65	8.012326656394453E-4		45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	3	5	3	5	6	4	18	32	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLV*GRHQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCAAGGGTACATGAACACTGAAGCTTTCTTTGGACAA	CASSLQGYMNTEAFF	In	VDJ	1	67	8.258859784283513E-4	0.0010843178507849167	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	5	3	0	3	4	18	32	39	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQGYMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCCGAGGACAGGGGGGGACCTACGAGCAGTACTTCGGGCCG	CASSLARGQGGTYEQYF	In	VDJ	1	67	8.258859784283513E-4	0.0010843178507849167	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	1	2	7	3	18	32	49	39	52														CASSLARGQGGTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTAGACAGGGACAGATCGGGAACACTGAAGCTTTCTTTGGACAA	CASSLRQGQIGNTEAFF	In	VDJ	1	71	8.751926040061633E-4	0.001149053244861628	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	1	8	5	18	30	45	38	50														CASSLRQGQIGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGAGCGGACACTTTACGAGCAGTACTTCGGGCCG	CASSFERTLYEQYF	In	VDJ	1	73	8.998459167950694E-4	0.0011814209418999839	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	1	6	4	5	3	18	32	42	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFERTLYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACAAGGTGACGGTAATCAGCCCCAGCATTTTGGTGAT	CASSLQGDGNQPQHF	In	VDJ	1	74	9.121725731895224E-4	0.0011976047904191617	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	2	2	7	4	6	3	18	33	42	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQGDGNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACAGCTCGGGGGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	76	9.368258859784284E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	8	1	6	7	0	18	34	-1	41	48														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACGACAGTCGAACACTGAAGCTTTCTTTGGACAA	CASSLRQSNTEAFF	In	VDJ	1	77	9.491525423728814E-4	0.0012461563359766952	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	5	1	1	2	18	33	39	34	41														CASSLRQSNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTGGACAGCCGATGATTCACCCCTCCACTTTGGGAAC	CASSSWTADDSPLHF	In	VDJ	1	80	9.861325115562403E-4	0.0012947078815342288	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	1	5	8	3	6	18	31	40	34	46														CASSSWTADDSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACTAGCGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSLGLAGTGELFF	In	VDJ	1	80	9.861325115562403E-4	0.0012947078815342288	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	2	3	5	0	0	18	-1	-1	34	45														CASSLGLAGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCGGACGGGGCAGGGAAACACCATATATTTTGGAGAG	CASSRTGQGNTIYF	In	VDJ	1	81	9.984591679506934E-4	0.0013108917300534066	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	6	7	0	4	6	2	18	29	40	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTGQGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGGTGAGCGATCACGGACAGATACGCAGTATTTTGGCCCA	CASSPGERSRTDTQYF	In	VDJ	1	89	0.0010970724191063175	0.0014403625182068296	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	6	3	7	7	18	30	41	37	48						01,02								CASSPGERSRTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGTGGGACTACACAGATACGCAGTATTTTGGCCCA	CASSSWDYTDTQYF	In	VDJ	1	101	0.0012449922958397534	0.001634568700436964	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	9	2	3	0	18	31	-1	34	41						01,02								CASSSWDYTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGACAGACAGGGCTCAGGGAGCTGTTTTTTGGAGAA	CASSRQTGLRELFF	In	VDJ	1	107	0.0013189522342064715	0.0017316717915520311	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	3	9	5	4	18	30	42	35	46														CASSRQTGLRELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCCCCTAGCGCGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLSPSAANTGELFF	In	VDJ	1	107	0.0013189522342064715	0.0017316717915520311	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	4	6	0	4	3	18	33	43	37	46						01,02								CASSLSPSAANTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAACAGGGAAAAACTATGGCTACACCTTCGGTTCG	CASSLETGKNYGYTF	In	VDJ	1	114	0.0014052388289676424	0.001844958731186276	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	3	2	1	3	18	35	42	36	45														CASSLETGKNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCGCCCGACAGGCGCCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	122	0.0015038520801232665		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	4	17	6	18	18	33	45	39	63														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTCAGGGGGCAAAACAATGAGCAGTTCTTCGGGCCA	CASSLVRGQNNEQFF	In	VDJ	1	124	0.0015285053929121725	0.0020067972163780546	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	0	5	3	3	18	32	43	35	46														CASSLVRGQNNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAATAGCGGGGGGAGCAGGACAGATACGCAGTATTTTGGCCCA	CASSNSGGSRTDTQYF	In	VDJ	1	133	0.0016394453004622497	0.0021524518530506554	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	5	1	3	2	6	18	30	42	32	48														CASSNSGGSRTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGAGAATTCGACTAGCGATCGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	135	0.0016640986132511557		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	2	6	5	4	5	18	35	47	39	52						01,02								X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGGATTAGCGGGACGCTACAATGAGCAGTTCTTCGGGCCA	CASSLDGLAGRYNEQFF	In	VDJ	1	135	0.0016640986132511557	0.002184819550089011	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	5	3	3	5	2	18	35	48	40	50														CASSLDGLAGRYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTGACAGTCACAGATACGCAGTATTTTGGCCCA	CASSLLTVTDTQYF	In	VDJ	1	158	0.0019476117103235748	0.002557048066030102	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	5	2	2	1	18	33	40	35	41														CASSLLTVTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGACAGGGTCTAATGAAAAACTGTTTTTTGGCAGT	CASSLETGSNEKLFF	In	VDJ	1	163	0.0020092449922958396	0.0026379673086259913	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	2	3	3	0	1	18	-1	42	35	43														CASSLETGSNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACCCGGGGGCGGGGGAGAGACCCAGTACTTCGGGCCA	CASSSPGGGGETQYF	In	VDJ	2	242	0.002983050847457627	0.003916491341641042	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	7	2	4	9	0	18	31	-1	40	47														CASSSPGGGGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTGATGAGAAGGTGAAAAACTGAAGCTTTCTTTGGACAA	CASSLVMRR*KTEAFF	Stop	VDJ	2	251	0.003093990755007704		48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	5	4	5	10	6	18	32	45	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVMRR*KTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGACGGAGCGGCTCGGACTATGGCTACACCTTCGGTTCG	CASSGRSGSDYGYTF	In	VDJ	2	256	0.003155624036979969	0.0041430652209095324	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	6	5	3	6	5	18	30	41	36	46						01,02								CASSGRSGSDYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACTAGCGGGGAAGAGACCCAGTACTTCGGGCCA	CASSLTSGEETQYF	In	VDJ	9	1237	0.015248073959938368	0.020019420618223014	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	3	3	3	0	0	18	-1	-1	33	43														CASSLTSGEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTGCATAGCAGGACGAGCAGTACGTCGGGCCG	CASSLVA*QDEQYV	Stop	VDJ	25	3495	0.04308166409861325		42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	1	1	7	17	10	10	18	34	48	44	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVA*QDEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCGACTCATGGGATACGCAGTATTTTGGCCCA	CASTDSWDTQYF	In	VDJ	1	44	5.423728813559322E-4	7.120893348438259E-4	36	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	12	2	10	6	7	5	26	31	42	38	47						01,02								CASTDSWDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCCGCCCCTCGCGGTCAGGGGTGAAGCATGGCTACACCTTCGGTTCG	CASRPSRSGVKHGYTF	In	VDJ	1	52	6.409861325115563E-4	8.415601229972488E-4	48	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	12	4	2	6	17	6	26	31	54	48	60														CASRPSRSGVKHGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCATTTACCTGACCGGGGAGCTGTTTTTTGGAGAA	CAIYLTGELFF	In	VDJ	1	56	6.902927580893683E-4	9.062955170739601E-4	33	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-02	01	12	3	7	5	5	3	26	31	38	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIYLTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01		TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCGGTACTCCTTAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	79	9.738058551617874E-4		41	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	3	10	2	0	5	26	-1	41	38	46						01,02								X+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD02-01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTACTGGAAGGACAGGTGCCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	177	0.002181818181818182		53	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	1	4	4	7	3	26	43	57	50	60														X+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTAGAGCCTAACACTGAAGCTTTCTTTGGACAA	CASGLEPNTEAFF	In	VDJ	1	186	0.0022927580893682587	0.003010195824567082	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	6	7	2	2	2	26	40	45	42	47						01,02								CASGLEPNTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD02-01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGGATCCCCGCCTCCGGAAGCACACCTACGAGCAGTACGTCGGGCCG		Out	VDJ	3	457	0.005633281972265023		47	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-07	01	9	1	8	17	13	21	26	34	50	47	71				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01		TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAAAGGGACAGTTGAGACCCAGTACTTCGGGCCA	CASKGTVETQYF	In	VDJ	9	1240	0.015285053929121726	0.020067972163780548	36	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	12	0	5	5	7	2	26	31	45	38	47														CASKGTVETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAGGTGTCAAGAACACTGAAGCTTTCTTTGGACAA	CASSQGVKNTEAFF	In	VDJ	1	109	0.0013436055469953775	0.0017640394885903867	42	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	2	0	10	1	0	6	20	-1	37	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGVKNTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCTAAGGGCAGGGTCCGAGCAATGAGCAGTTCTTTGGGCCA		Out	VDJ	1	113	0.0013929121725731895		50	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02			0	4	3	22	6	22	20	37	48	43	70								TCRBJ02-01,TCRBJ02-05						X+TCRBV23-01+TCRBJ02-X	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAGGGACTCCTCCGGGATACGCAGTATTTTGGCCCA	CASSQGLLRDTQYF	In	VDJ	1	118	0.0014545454545454545	0.0019096941252629875	42	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	10	6	3	7	20	31	40	34	47						01,02								CASSQGLLRDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD02-01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCAGGGGCAGGGCAATCCTCGTCAGGTGAGCAGTTCTTCGGGCCA	CASSPGAGQSSSGEQFF	In	VDJ	1	39	4.807395993836672E-4	6.311700922479365E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	2	9	2	19	23	34	42	36	61														CASSPGAGQSSSGEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCGAGGCAGGGCGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFEAGRNTGELFF	In	VDJ	1	39	4.807395993836672E-4	6.311700922479365E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	1	6	2	23	36	47	42	49														CASSFEAGRNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACGACAGGGTGACTATGGCTACACCTTCGGTTCG	CASRRQGDYGYTF	In	VDJ	1	45	5.546995377503852E-4	7.282731833630037E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	3	2	2	23	34	43	36	45														CASRRQGDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTCGGACCCCAGGATACGCAGTATTTTGGCCCA	CASSVGPQDTQYF	In	VDJ	1	45	5.546995377503852E-4	7.282731833630037E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	5	1	7	6	3	5	23	35	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGPQDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTCTGTAACTCGTAGATACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	45	5.546995377503852E-4		55	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	5	3	6	5	15	5	23	35	53	50	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCACTAGCGGGGGGAAGAATGGGTACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	46	5.670261941448382E-4		59	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	3	1	2	0	11	22	-1	51	39	62														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGTATCTGGGGGCAGTTCTTCGGGCCA	CASSYGIWGQFF	In	VDJ	1	47	5.793528505392912E-4	7.606408804013595E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	2	6	2	12	7	0	23	38	-1	45	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGIWGQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGCTACAGGGAACACTGAAGCTTTCTTTGGACAA	CASSATGNTEAFF	In	VDJ	1	48	5.916795069337442E-4	7.768247289205373E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	4	1	4	0	23	34	-1	38	43														CASSATGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTATTGCGGGAGCTAACTATGGCTACACCTTCGGTTCG	CASSPIAGANYGYTF	In	VDJ	1	50	6.163328197226503E-4	8.091924259588931E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	7	2	0	6	0	23	35	-1	41	48														CASSPIAGANYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAAATGAACACTGAAGCTTTCTTTGGACAA	CASSQMNTEAFF	In	VDJ	1	51	6.286594761171033E-4	8.253762744780709E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	6	0	0	2	23	-1	37	35	39														CASSQMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGTAGGGACTAGTCTCGATGAGCAGTTCTTCGGGCCA	CASVGTSLDEQFF	In	VDJ	1	51	6.286594761171033E-4	8.253762744780709E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	0	8	8	3	5	23	32	43	35	48						01,02								CASVGTSLDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGCGGGCAGGGGCGATCGCCGAGGCTACACCTTCGGTTCG	CAISAGRGDRRGYTF	In	VDJ	1	52	6.409861325115563E-4	8.415601229972488E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	2	8	5	10	23	35	46	40	56														CAISAGRGDRRGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCCCGGGACTAATGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYSPGLMNTGELFF	In	VDJ	1	59	7.272727272727272E-4	9.548470626314937E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	0	9	1	3	2	23	40	50	43	52						01,02								CASSYSPGLMNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGAGCATCGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	61	7.519260400616332E-4		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	8	5	23	35	47	43	52														X+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGAAAAGCCCCAGCATTTTGGTGAT	CASSYGEKPQHF	In	VDJ	1	65	8.012326656394453E-4	0.001051950153746561	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	2	0	8	8	1	2	23	38	43	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGEKPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCAACGCCCACATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	65	8.012326656394453E-4		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	6	0	8	0	23	36	-1	44	47														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCACGGCCCAGGGGGCGCTTATCAGCCCCAGCATTTTGGTGAT	CASSHGPGGAYQPQHF	In	VDJ	1	69	8.505392912172573E-4	0.0011166855478232723	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	0	5	7	4	23	35	50	42	54														CASSHGPGGAYQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGCCGGGGACAATGAGCAGTTCTTCGGGCCA	CASSYSAGDNEQFF	In	VDJ	1	70	8.628659476117103E-4	0.0011328693963424503	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	3	5	3	0	23	40	-1	43	48														CASSYSAGDNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATAGGACACCGGCCGCTGAAGCTTTCTTTGGACAA	CASSYRTPAAEAFF	In	VDJ	1	73	8.998459167950694E-4	0.0011814209418999839	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	6	6	2	7	23	37	44	39	51														CASSYRTPAAEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGGGACAGGGCTCCACGAGCAGTACTTCGGGCCG	CASTGTGLHEQYF	In	VDJ	1	75	9.244992295839754E-4	0.0012137886389383395	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	3	5	2	4	23	33	44	35	48														CASTGTGLHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCAGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSGSSYNEQFF	In	VDJ	1	77	9.491525423728814E-4	0.0012461563359766952	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	8	4	3	0	1	2	23	32	38	33	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTGGGCCGAAACGGGAAACACCATATATTTTGGAGAG	CASSYSWAETGNTIYF	In	VDJ	1	83	0.0010231124807395995	0.0013432594270917624	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	8	0	4	2	7	23	40	46	42	53														CASSYSWAETGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACACCAGGGGCTGGACAGCCCCAGCATTTTGGTGAT	CASSTPGAGQPQHF	In	VDJ	1	86	0.0010600924499229584	0.001391810972649296	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	2	7	4	5	23	35	45	39	50														CASSTPGAGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGACAGGGGAGGTGAAAAACTGTTTTTTGGCAGT	CASDRGGEKLFF	In	VDJ	1	87	0.0010724191063174115	0.0014079948211684738	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	2	2	7	0	3	23	-1	40	32	43														CASDRGGEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGGGGTGAGCGGGGGGGCCCCGGGGAGCAGTTCTTCGGGCCA	CASSYRGERGGPGEQFF	In	VDJ	1	89	0.0010970724191063175	0.0014403625182068296	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	6	0	10	7	7	23	38	55	45	62														CASSYRGERGGPGEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACGTACCGGGACGGATGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	91	0.0011217257318952233		47	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	7	0	7	1	6	4	23	33	44	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCATTTTCAATGAGCAGTTCTTCGGGCCA	CASSYSIFNEQFF	In	VDJ	1	93	0.0011463790446841293	0.001505097912283541	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	6	6	0	4	23	-1	42	40	46														CASSYSIFNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCCGGGACAGTACAGACAGATACGCAGTATTTTGGCCCA	CASRPGTVQTDTQYF	In	VDJ	1	98	0.0012080123266563945	0.0015860171548794304	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	5	3	4	5	23	34	45	38	50														CASRPGTVQTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACCAAAGGACAGGGTGGTTCACCCCTCCACTTTGGGAAC	CASSTKGQGGSPLHF	In	VDJ	1	98	0.0012080123266563945	0.0015860171548794304	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	1	3	9	7	3	23	34	49	41	52														CASSTKGQGGSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCTAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	98	0.0012080123266563945		41	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	8	3	6	5	4	5	23	32	39	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTGTCCAAGTCTCCTAGTCGACAATGAAAAACTGTTTTTTGGCAGT	CASSDCPSLLVDNEKLFF	In	VDJ	1	102	0.0012573189522342065	0.0016507525489561417	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	4	8	5	11	5	23	39	54	50	59						01,02								CASSDCPSLLVDNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATCGACAGGGGGAAGCTACGAGCAGTATGTCGGGCCG	CASRSTGGSYEQYV	In	VDJ	1	109	0.0013436055469953775	0.0017640394885903867	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	1	17	3	17	23	34	46	37	63														CASRSTGGSYEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACAGCGGACACTGAAGCTTTCTTTGGACAA	CASSYSTADTEAFF	In	VDJ	1	110	0.0013559322033898306	0.0017802233371095647	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	2	5	3	0	3	23	-1	45	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSTADTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAGGGGGCGGGCAGCCCCAGCATTTTGGTGAT	CASKGGGQPQHF	In	VDJ	1	123	0.0015161787365177196	0.0019906133678588766	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	5	0	7	1	3	23	33	41	34	44														CASKGGGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGGCGAGTCCTACGAGCAGTACTTCGGGCCG	CASRGESYEQYF	In	VDJ	1	123	0.0015161787365177196	0.0019906133678588766	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	5	4	1	0	4	23	-1	37	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGESYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGACGGCGGACTAGCGGGGGCGTATACGCAGTATTTTGGCCCA	CASRDGGLAGAYTQYF	In	VDJ	1	128	0.0015778120184899846	0.0020715326104547662	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	1	2	7	7	3	23	34	54	41	57														CASRDGGLAGAYTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTTAGCGGGAGGGGAGTTTGAGCAGTTCTTCGGGCCA	CASSDLAGGEFEQFF	In	VDJ	1	130	0.0016024653312788906	0.002103900307493122	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	5	0	9	0	5	23	-1	50	39	55														CASSDLAGGEFEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCATTTCTAGTGGAGGACTTTACGAGCAGTACTTCGGGCCG	CASSPISSGGLYEQYF	In	VDJ	1	131	0.0016147919876733437	0.0021200841560123	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	1	10	4	16	1	23	34	55	50	56						01,02								CASSPISSGGLYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAAGGGTTCGGACACTGAAGCTTTCTTTGGACAA	CASSYKGSDTEAFF	In	VDJ	1	131	0.0016147919876733437	0.0021200841560123	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	5	3	3	1	5	23	38	43	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYKGSDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAAATAGATATCCCGCTGGCAGTCTGTGTCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	135	0.0016640986132511557		62	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	2	4	5	4	18	7	19	34	55	52	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCGACAGGATGTAGGGTACGAGCAGTACTTCGGGCCG	CASRRQDVGYEQYF	In	VDJ	1	143	0.0017627118644067796	0.002314290338242434	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	4	4	2	8	23	34	42	36	50														CASRRQDVGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTCACGGTAAACACTGAAGCTTTCTTTGGACAA	CASSVTVNTEAFF	In	VDJ	1	158	0.0019476117103235748	0.002557048066030102	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	5	2	4	2	23	35	42	39	44						01,02								CASSVTVNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGCGGGGGCTCCGCACAGATACGCAGTATTTTGGCCCA	CASSERGLRTDTQYF	In	VDJ	1	160	0.0019722650231124806	0.0025894157630684577	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	6	2	1	1	4	23	35	44	36	48														CASSERGLRTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGGGACAGGGACCAATGAGCAGTTCTTCGGGCCA	CASTGTGTNEQFF	In	VDJ	1	171	0.0021078582434514636	0.002767438096779414	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	3	6	2	2	23	33	44	35	46														CASTGTGTNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACGGGGATCGGCTTGAATGAGCAGTTCTTCGGGCCA	CASTGIGLNEQFF	In	VDJ	1	177	0.002181818181818182	0.002864541187894481	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	8	3	7	0	9	23	-1	38	33	47														CASTGIGLNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGCCAGGGGGCCACACCCCTCCACTTTGGGAAC	CASSYSQGATPLHF	In	VDJ	1	180	0.002218798151001541	0.0029130927334520148	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	4	0	11	3	2	23	38	49	41	51														CASSYSQGATPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAATTCGGGCGGGCAGTTCTTCGGGCCA	CASSYSNSGGQFF	In	VDJ	1	182	0.0022434514637904466	0.002945460430490371	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	0	8	0	12	6	2	23	40	50	46	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSNSGGQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACGGGGTTGGTGGAGACCCAGTACTTCGGGCCA	CASTGLVETQYF	In	VDJ	1	185	0.002280431432973806	0.0029940119760479044	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	8	3	5	0	6	23	-1	38	33	44														CASTGLVETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACAGGGCCCAAAGGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSTGPKGSNQPQHF	In	VDJ	1	187	0.0023050847457627118	0.00302637967308626	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	3	1	1	9	23	34	41	35	50														CASSTGPKGSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTGGACAGGGTCTCAATGAGCAGTTCTTCGGGCCA	CASTGQGLNEQFF	In	VDJ	1	194	0.0023913713405238827	0.003139666612720505	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	1	3	6	2	3	23	33	43	35	46														CASTGQGLNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAACCCCGGGCCGGCTGAAGCTTTCTTTGGACAA	CASRNPGPAEAFF	In	VDJ	1	204	0.002514637904468413	0.0033015050979122835	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	8	0	6	7	3	23	34	45	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRNPGPAEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGAGGAGGGCTCCACGAGCAGTACTTCGGGCCG	CASSGGGLHEQYF	In	VDJ	1	206	0.002539291217257319	0.003333872794950639	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	0	5	3	4	23	35	44	38	48														CASSGGGLHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCCTCAGGGAGTCTACAATGAGCAGTTCTTCGGGCCA	CASSDPQGVYNEQFF	In	VDJ	2	215	0.002650231124807396	0.00347952743162324	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	4	3	3	6	3	23	35	46	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDPQGVYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGACGGTGACAATGAGCAGTTCTTCGGGCCA	CASSYSDGDNEQFF	In	VDJ	2	220	0.002711864406779661	0.0035604466742191294	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	0	1	7	5	0	4	23	-1	44	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSDGDNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACGGGGACCGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRRGPATNEKLFF	In	VDJ	2	248	0.003057010785824345	0.004013594432756109	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	6	0	7	0	3	3	23	34	42	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRGPATNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAAAGGGGGCCGCGTCTCGGAACTGTTTTTTGGCAGT	CASSYSKGGRVSELFF	In	VDJ	2	257	0.0031679506933744222	0.0041592490694287105	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	5	0	12	3	10	23	40	50	43	60														CASSYSKGGRVSELFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTGGAGCCGGGACGAACGAGCAGTAYTTCGGGCCG	CASTGAGTNEQYF	In	VDJ	2	258	0.0031802773497688753	0.004175432917947888	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	7	0	7	16	8	13	23	33	46	41	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTGAGTNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTGCCGGGACAGGGCTCAATGAGCAGTTCTTCGGGCCA	CASAGTGLNEQFF	In	VDJ	2	287	0.0035377503852080123	0.004644764525004046	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	0	3	6	4	2	23	31	44	35	46														CASAGTGLNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGACTAGCGGGCCCAGCACAGATACGCAGTATTTTGGCCCA	CASSWTSGPSTDTQYF	In	VDJ	2	305	0.0037596302003081662	0.004936073798349248	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	4	0	0	3	23	-1	47	36	50						01,02								CASSWTSGPSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCATGGGGCCTAGGGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSMGPRGSNQPQHF	In	VDJ	2	310	0.0038212634822804314	0.005016993040945137	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	5	2	0	10	0	23	34	-1	44	49														CASSMGPRGSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATAGGCGGGGGTTTGAACATTCAGTACTTCGGCGCC	CASIGGGLNIQYF	In	VDJ	4	530	0.006533127889060093	0.008577439715164266	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	7	7	2	7	3	4	23	33	43	36	47														CASIGGGLNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-04*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGGTACAGGGCTAAATGAGCAGTTCTTCGGGCCA	CASTGTGLNEQFF	In	VDJ	32	4392	0.0541386748844376	0.07107946269622917	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	3	3	7	5	3	23	33	44	38	47														CASTGTGLNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATGATCGGGGGAGCGGGTTAGTACTTCGGGCCG		Out	VDJ	1	59	7.272727272727272E-4		41	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	6	4	11	10	2	24	39	55	49	57						01,02							Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCTCGGACAGGCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPRTGANTGELFF	In	VDJ	1	66	8.135593220338983E-4	0.0010681340022657387	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	4	0	5	2	24	35	47	40	49													Vb 18	CASSPRTGANTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCAGAAAACTATGGCTACACCTTCGGTTCG	CASSPAENYGYTF	In	VDJ	1	75	9.244992295839754E-4	0.0012137886389383395	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	5	2	1	2	24	39	43	40	45													Vb 18	CASSPAENYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCATGGGACAGGGGGACACTGAAGCTTTCTTTGGACAA	CASSPMGQGDTEAFF	In	VDJ	1	83	0.0010231124807395995	0.0013432594270917624	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	1	3	3	0	24	38	-1	41	52													Vb 18	CASSPMGQGDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCTGGACGTGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	86	0.0010600924499229584		43	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	1	7	4	4	3	24	38	46	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAACTCACCTGACTATAATTCACCCCTCCACTTTGGGAAC	CANSPDYNSPLHF	In	VDJ	1	118	0.0014545454545454545	0.0019096941252629875	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-06	01	3	2	8	3	1	0	24	38	-1	39	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CANSPDYNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01		TCRBJ01-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATACAGCAAGGACATTTACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	159	0.001959938366718028		55	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	8	10	24	36	49	44	59													Vb 18	X+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTGGGACAGGGGGTTCGCGAGCAGTACGTCGGGCCG	CASSLGQGVREQYV	In	VDJ	1	176	0.002169491525423729	0.0028483573393753036	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	1	17	1	15	24	37	49	38	64													Vb 18	CASSLGQGVREQYV+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGCGGGGTGGAGAGACCCAGTACTTCGGGCCA	CASSPGRGGETQYF	In	VDJ	3	353	0.00435130970724191	0.005712898527269784	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	7	3	4	3	3	24	38	47	41	50													Vb 18	CASSPGRGGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-05*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAAGTCCTTCACTCTAACACTGAAGCTTTCTTTGGACAA	CASSPQVLHSNTEAFF	In	VDJ	6	841	0.010366718027734976	0.01361061660462858	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	3	10	2	9	2	24	40	52	49	54						01,02							Vb 18	CASSPQVLHSNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	9717A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				709	540	133	35	0	475	384	85	6	0	81125	61790	15308	4027	0	0.0911552459	7.8023982	0.0986395478	8.01470184				71895	0.008004874153939823	0.0710794628	0.0541386753	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:03	Age (Range):65+ Years (Old Age),Age:69 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 631,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 299,treatment:nact,type of chemo:carbo/taxol	0.761636086433755	MSKCC- Snyder- P01-01		576.0	
